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Abstract
A hybrid mode of hydrophobic interaction chromatography (HHIC) is an emerging
chromatographic technique for the separation of biomolecules under non-denaturing conditions.
This technique separates biomolecules in their native form where the difference in surface
hydrophobicity is maximized. Hybrid mode of HIC (HHIC) methodology uses HIC stationary
phases made with poly (alkyl aspartamide) silica columns, which function as a hybrid form of
conventional HIC and reversed-phase chromatography (RPLC). This research provided
fundamental knowledge about the impact of chromatographic parameters on the separation of coformulated mAbs. The influence of mobile phase parameters such as salt concentration, pH and
the role of organic modifier and as well as stationary phase parameters on the separation were
evaluated. This research demonstrated that an adequate chromatographic separation of mAbs and
related biomolecules was achieved using a low ammonium acetate concentration which was not
achieved with model proteins previously. The study showed the analytical utility of low
ammonium acetate condition (0.5M) to widen the chromatographic elution window by eluting
early eluters faster and late eluters later and also an increase in peak capacity. In addition, low
ammonium acetate concentration showed a five-fold increase in ESI intensity, which is an
advantage for online MS.
In Chapter 1, a brief review of the theory, principles of the methodology and the details
about the poly (alkyl aspartamide) silica columns is provided. In addition, the area of interest and
the scope of the research is presented. In Chapter 2, the impact of salt concentration and organic
modifier on the separation of therapeutic monoclonal antibodies and related biomolecules is
presented. Data demonstrated that using these columns, with low concentrations of ammonium
acetate, a small portion of organic solvent is required to elute biomolecules in a reasonable time
frame. The research showed chromatographic separation is achievable under low ammonium
acetate conditions and also helps to widen the chromatographic window. Assessment of
conformational changes in the presence of moderate organic content using orthogonal methods is
also presented. This chapter demonstrates the impact of linear flow velocity and gradient time on
chromatographic efficiency using these columns. Chapter 3 presented how pH of the mobile
phase can help tune the chromatographic separation along with the impact of temperature on the
separation.
In the literature it was clearly discussed that to obtain adequate separation using
ammonium acetate, a pentyl alkyl chain is required. This fact indicates that hydrophobicity of the
stationary phase has a great influence on retention. In Chapter 4, the effect of alkyl chain length
and the impact of hydrophobicity on selectivity along with the interdependencies of mobile
phase parameters and the stationary phase is presented. HHIC chromatographic parameters such
as organic modifier can induce conformational changes in biomolecules. Intrinsic fluorescence
was used to gain basic knowledge on the conformational changes of a biomolecule. Chapter 5
provides the experimental results of conformational changes which were obtained using an
offline batch mode of intrinsic fluorescence and provided fundamental knowledge about possible
conformational changes in the presence of poly (alkyl aspartamide) silica columns using hybrid
HIC mobile phases.
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Chapter 1 : Introduction and Recent Advances in HHIC Using Poly
(alkyl aspartamide) Silica Columns
1.1 Overview
For the past three decades, therapeutic monoclonal antibodies (mAbs) and their
derivatives have become the most promising and fastest growing therapeutics to treat various
diseases such as cancer, autoimmunity, metabolic disorders, and infections

1-2

. The unique

pharmacological advantages of mAbs (e.g., target specificity, selectivity, long half-life, and
excellent safety profile) and the evolving protein engineering (bispecific antibody, fusion
protein, antibody-drug conjugate, and nanobody) continuously drive the development of new
mAb-based therapeutics. Therapeutic monoclonal antibodies act through multiple mechanisms,
such as blocking of targeted molecule functions, inducing apoptosis in cells which express the
target, or by modulating signaling pathways

3-4

. Monoclonal antibodies treat immunotherapeutic

diseases, because each type of monoclonal antibody will target a specific targeted antigen in the
body. Over 40 therapeutic antibodies have been already approved and more than 450 molecules
are currently at different stages of clinical development

5-6

. Similar to antibodies, mAb-based

antibody drug conjugates (ADCs) and related products such as Fc fusion proteins also gaining
more attention to treat various deceases 7-9. There are over 60 ADCs currently at the development
stage for various indications 10-14
In recent years, along with mono therapeutics, developing combination drugs became very
important due to potential advantages. For example, combination drugs provide an option to use
drugs at lower doses, reducing side effects but increasing efficacy, therefore very well
established in therapeutic area. Combination drugs present a promising approach for cancer
research

15-19

, viral diseases

20

and anti-toxins

21

18

. The combination of two or more human

monoclonal antibodies (mAbs) co-formulated into a single drug product has advantages such as
reducing medications errors, easy to use

and patient safety

22

. In practice, combination

chemotherapy results in a better response and improved survival compared with single-agent
therapy. Compared to marketed small molecule combination products, the number of coformulated biologics are very limited

23-25

. However, the interest is growing. So far only one

protein co-formulation containing rituximab (MabThera) and human hyaluronidase is currently
marketed to treat

26

and other examples include the combination of Platinol (cisplatin) and

Navelbine (vinorelbine) to treat non-small cell lung cancer and TCH (Taxol, carboplatin, and
Herceptin) for the treatment of HER2/neu-positive tumors 27-28.
MAbs and their derivatives are considered the most complex biologics due to their complex
conformational and structural dynamics, large molecular sizes, and micro heterogeneity caused
by various post-translational modifications. Because of their nature these molecules offer great
analytical challenges in characterization. To ensure the product quality, comprehensive
characterization and quantitation of each intact protein and all its variants is very crucial 29 30. In
addition, co-formulation of therapeutic antibodies increases the complexity of the drug product.
Therefore, the characterization and release assay development 31 can be extremely challenging. It
gets more complicated when the co-formulated antibodies have similar physicochemical
properties and wide disparity in their concentrations. Even though there are robust analytical
methods such as reversed-phase (RPLC), size exclusion (SEC), ion exchange (IEX),
hydrophobic interaction chromatography (HIC) or affinity chromatography available, it can be
highly challenging to characterize biomolecules in combination products due to the ratio of the
molecules in the drug product. The reason being each of the co-formulated antibodies can exist
in various heterogeneities such as size, charge, and post-translational modifications (PTMs)
19

32-33

during manufacturing 34-35. As combination therapy is a growing strategy, only limited analytical
methods have been reported to measure quality attributes in combination biomolecule
formulations 22.

1.2 Monoclonal Antibodies
MAbs (Figure 1.1) are glycoproteins, produced by a single clone of cells or cell line and
consisting of identical antibody molecules. Derivation from a single B-cell clones, having
monovalent affinity and subsequent targeting of a single epitope is what differentiates
monoclonal antibodies from polyclonal antibodies.

Figure 1.1 NIST mAb
https://www.nist.gov/news-events/news/2018/12/nist-2d-nmr-fingerprinting-study-givesbiopharmaceutical-sector-new-power
Source: www.nist.gov
20

1.2.1 Classification of antibodies
Humans have 5 classes (Figure 1.2) of antibodies (interchangeably used with
Immunoglobulins or IgGs): IgG, IgA, IgD, IgE and IgM. All 5 classes are secreted by activated
B cells as glycoproteins. These glycoproteins are produced by the immune system specifically
bind to antigen. IgG antibodies are the most common and the most important. As these are the
smallest, they can easily move across the cell membranes and circulate in the blood and other
body fluids, protecting against bacteria and viruses. They also bind to the antigens to enhance the
effectiveness of phagocytosis. Compared to other antibodies IgGs have highest half-life of about
21-23 days 36.

Figure 1.2 Types for Antibodies
https://commons.wikimedia.org/wiki/File:Figure_42_03_02.jpg
Source: commons.wikimedia.org

21

Through the process of hyper mutation and class switching, high affinity IgGs are
produced. Human IgG is further subdivided into IgG1, IgG2, IgG3 and IgG4 isotypes (Figure
1.3), which differ in their heavy chain. They are highly homologous and differ mainly in the
hinge region and their function in activating the host immune system. IgG1 and IgG4 contain
two inter-chain disulfide bonds in the hinge region where as IgG2 has four and IgG3 has eleven
37 -3 8

. The elongated hinge in IgG3 is also responsible for its higher molecular weight compared

to the other subclasses. Even though IgG1 and IgG4 have similar structures, the hinge region of
IgG4 is shorter than that of IgG1 and its flexibility is intermediate between that of IgG1 and
IgG2. The CH2 domain of IgG4 has its most marked differences with IgG1 in a surface-exposed
patch of the C terminal part of the domain, which in the 3D structure is close to the hinge

39

.

IgG1, 2 and 4 widely used in therapeutics, however, IgG2 do not cross the placenta as readily as
other human IgG isotypes and IgG3, which has a shorter serum half-life, is rarely used

30

.

Figure 1.3. Types of IgGs
https://www.burnet.edu.au/projects/229_igg_subclasses_and_immunity_to_malaria
Source: www.burnet.edu.au
(Reprinted with the permission of Burnet Institute)
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Table 1.1. IgG Antibody Isotype Comparison
Property

IgG1

IgG2

IgG3

IgG4

Molecular Weight (KDa)

146

146

170

146

Amino acids in hinge region

15

12

62

12

Inter-H chain disulfide bonds

2

4

11

2

Half-life (days)

~21

~21

7

~21

Relative abundance (%)

60

32

4

4

1.2.2 Antibody structure
Antibody molecules are roughly Y-shaped molecules (Figure 1.4) consisting of three
equal-sized portions, loosely connected by a flexible chain 40. Each chain has a tertiary structure
consisting of distinct domains. Each domain in an antibody has a very similar structure of two
beta sheets packed closely against each other. This whole assembly is finally into a quaternary
structure and stabilized by various interactions such as ionic interactions and hydrogen bonds
(Refer to section 1.2.3). IgG antibody is composed of one or more units, each containing four
polypeptide chains: two identical heavy chains (H) and two identical light chains (L)

37

. Each

heavy chain has about 500 amino acids and a molecular weight of ~50 kDa, as each light chain
has about 210 amino acids and a molecular weight of ~25 kDa, resulting in a total
immunoglobulin monomer molecular weight of approximately 150 kDa. The two heavy chains
are each linked to each other and to a light chain by disulfide bonds. The resulting tetramer has
two identical halves. Each end of the fork contains an identical antigen binding site, thus, each
IgG has two antigen binding sites. The amino terminal ends of the polypeptide chains show
considerable variation in amino acid composition and are referred to as the variable (V) regions
to distinguish them from the relatively constant (C) regions. Each L chain consists of one
23

variable domain, VL, and one constant domain, CL. The H chains consist of a variable domain,
VH, and three constant domains CH1, CH2 and CH3. CH2 domain is overlaid by an
oligosaccharide (N-glycosylation) covalently attached as Asn297

41

. There are three

complementarity-determining regions (CDRs) in each light chain and heavy chain variable
region, where antibodies bind to their specific antigen.

Figure 1.4. Structure of an Antibody
www.bing.com/images/search?view=detailV2&ccid=QWoTyXet&id=772E1BA31E4E8C7AE88
C19125374F346613EB920&thid=OIP.QWoTyXetrFsRrLFSEC0OfAAAAA&mediaurl=http%3a
%2f%2fi.stack.imgur.com%2f2DGzI.jpg&exph=357&expw=459&q=structure+of+an+antibody
&simid=608045000885865324&selectedIndex=19&qft=+filterui%3alicense-L2_L3
Source: www.bing.com

1.2.3 Chemical bonds involved in antibody structure
The function of the mAb depends on the quaternary structure of the molecule. The
structure is stabilized with non-covalent interactions between CH3 domains and the inter chain
disulfide bonds at the hinge region. The tertiary structure (Figure 1.5) of proteins is determined
24

by a variety of attractive forces, including hydrophobic interactions, ionic bonding, hydrogen
bonding, and disulfide linkages. Individual amino acids are bonded together in a polypeptide
chain to make the backbone. The bonding interactions that are present in a mAb are hydrogen
bonding, ionic bridges (a salt bridge is a combination of two noncovalent interactions: hydrogen
bonding and electrostatic interactions), disulfide bonds, and hydrophobic intermolecular
interactions. Hydrogen bonds form between the oxygen of the C=O of each peptide bond in the
strand and the hydrogen of the N-H group of the peptide bond. Salt bridges, ionic interactions
between positively and negatively charged sites on amino acid side chains, will also help
stabilize the tertiary structure of a molecule. Cysteine will contribute to form disulfide bridges to
stabilize the tertiary structure, allowing different parts of the molecule chain to be held together
covalently. The alkyl groups of non-polar amino acids form hydrophobic interactions between
one-another. MAbs consist completely of beta sheets, which are stabilized with the help of
hydrogen bonds. The three-dimensional shape of the molecule and its function will be
determined based on all of these interactions.

Figure 1.5. Chemical bonds involved in tertiary structure
https://commons.wikimedia.org/wiki/File:OSC_Microbio_07_04_tertiary.jpg
Source: Courses.lumenlearning.com
25

1.3 Challenges in Analytical Characterization of Antibody and Related
Therapeutic mAbs are produced using living organisms and manufactured using complex
processes. As these biomolecules are very sensitive to process conditions, synthesis can cause
various post- and co-translational modifications introducing intrinsic heterogeneity
may affect biological activity resulting in molecular variability.

42

, which

Some of the structural

differences are glycoforms, charge variants, cysteine-related, oxidized amino acid side chains,
formation of aggregates, deamidation products as well as amino and carboxyl terminal amino
acid additions and low level point mutation variants

29, 43

. These small structural changes can

affect preclinical stability and process optimization in addition to therapeutic product potency,
bioavailability and immunogenicity. The development of a successful therapeutic mAb needs the
identification and manufacture of a selective and potent molecule that performs the required task,
humanization of sequences, affinity maturation, Fc engineering to modulate effector functions. In
addition, the development also requires proper engineering to address biophysical liabilities that
would negatively impact manufacturability and/or patient effectiveness.
Developing therapeutic biomolecules is a highly complex process and there are many
factors that can challenge the manufacturing, processing and storage, which can in turn cause
physical and chemical degradation of the product. The most common causes of physical
degradation are excessive temperature, mechanical, and freeze/thaw stresses. Chemical
degradation affects the primary sequence and may also lead to significant changes in the higher
order structure (HOS). Examples of chemical degradation include deamidation, oxidation,
isomerization, hydrolysis of a peptide bond, clipping/fragmentation, and cross-linking. The
reason that both physical and chemical degradation are so critical is that the efficacy of mAbbased therapeutics is closely tied to their structural, conformational, and chemical stability. To
26

deliver a therapeutic drug with a greater patient’s safety, characterization to understand structural
differences, physical degradation and chemical degradation are extremely important.
In addition to mAbs, Fc fusion proteins and ADCs which are manufactured by either
joining two or more genes that originally coded for separate biomolecules or an addition of the
drug payload to an already structurally-complex antibody via a linker molecule, characterization
of ADCs presents a substantial challenge from an analytical development perspective

44 45

.

Combining these complex molecules and making co-formulation of therapeutic antibodies
increases the complexity of the drug product. Therefore, the characterization and release assay
development 31, can be extremely challenging. It gets more complicated when the co-formulated
antibodies have similar physicochemical properties and significant difference in their
concentrations. Even though there are robust analytical methods available, it can be highly
challenging to characterize biomolecules in combination products due to the ratio of the
molecules in the drug product and each of the co-formulated antibodies can exist in various
heterogeneities in size, charge, and post-translational modifications (PTMs)
manufacturing

34-35

32-33

during

. As combination therapy is a growing strategy, only limited analytical

methods have been reported to measure quality attributes in combination biomolecule
formulations 22.

27

Figure 1.6. Mab and related biomolecules
There are various methods available to analyze biomolecules. However, many challenges
remain for top-down proteomics, including the challenges to separate biomolecules in their
native intact conformation

46-47

. There are several liquid chromatographic techniques that are

well established to characterize biomolecules, such as reversed-phase liquid chromatography
(RPLC), size exclusion chromatography (SEC), ion exchange chromatography (IEX) and
hydrophobic interaction chromatography (HIC). However, the ideal method is a liquid
chromatography (LC) which can use volatile mobile phases to separate complex mixtures. These
methods offer the advantage of an online separation with direct coupling to a mass spectrometer
and is compatible for automation where fraction collection process can be avoided to achieve
high-throughput analysis

48

.

However, the number of chromatography methods that are

compatible with online MS capability is limited

49

. Hydrophilic interaction chromatography

(HILIC) is one of the techniques which can be directly coupled with MS, but HILIC uses
solutions which contain high concentrations of organic solvent, which can then denature the
biomolecule

50

. The separation in Size Exclusion Chromatography (SEC) and Ion Exchange

Chromatography (IEC) is performed using a volatile buffer containing ammonium acetate. Even
though these techniques are compatible for MS

51

, SEC is not yet a high-resolution method

51

.

While IEC is a high-resolution method, complex protein mixtures often require more than one
28

dimension of fractionation

52

. Reversed-phase Chromatography (RPC) is the most commonly

used chromatographic method which is MS compatible

53-58

, and has been used in the

purification and analysis of biological molecules. Nevertheless, chromatographic conditions such
as high temperature, and mobile phase components such as high organic content and stronger
hydrophobic stationary phases can denature and expose numerous hydrophobic moieties of the
biomolecule

59-61

. This can cause adverse effects such as loss in biological activity, peak

broadening, low protein recovery, and also adsorbed on to highly hydrophobic stationary phase
resulting in failure to elute from the column
uncommon for large-scale protein separations

62

59

. Therefore, the use of RPLC methods is

and there is a need for additional methods for

online LC-MS that can provide high-resolution separation of a wide range of proteins with
minimal denaturation.
HIC is an alternate liquid chromatographic techniques for RPLC where the separation of
biomolecules is based on hydrophobicity. To overcome some of the RPLC challenges, HIC has
been used as an alternative method to separate proteins. The main advantage of HIC is that
separation can be achieved under protein native conditions where the differences in the surface
hydrophobicity will be maximized for molecules with high degree of sequence homology.
Although both HIC and RPLC separation mechanisms are based on hydrophobicity, HIC
separation is based on native surface hydrophobicity

63

and RPLC separation is based on the

hydrophobicity of either partially denatured protein or fully denatured protein. In addition, HIC
selectivity can be improved by modifying the column matrix surface, the alkyl chain bonding
density and mobile phase variables 64.
HIC is one of the most widely used techniques for determining the relative
hydrophobicity of mAbs, to separate the different populations of ADC molecules that differ in
29

their number of drugs per antibody (drug-to-antibody ratio) species and also to separate and
characterize their positional isomers

65-66

. The separated proteins can be collected for further

activity measurements (such as cell based potency, receptor binding, cell proliferation assay,
enzyme assay, functional enzyme linked immunosorbent assay (ELISA) and many more). HIC
has been a valuable tool in downstream purification process where it is frequently used for
protein purification based on the apparent hydrophobicity of impurities 63, 67-68. Due to the nature
of the technique, it gained a lot of importance in analytical separation of micro-heterogeneity in
mAbs caused by post translational modifications and the analysis of antibody drug conjugates.
Methionine and Tryptophan oxidation are common chemical modifications which affects the
activity loss in biomolecules 69. Oxidized mAb microvariants are generally characterized using a
bottom up (peptide mapping) approach and techniques such as HIC and RPLC 70. In a case study
Boyd et al

71

showed that HIC was able to isolate oxidized Trp IgGs from a basic peak hence

enabling the monitoring of Trp oxidation. In addition, HIC demonstrated the capability of
separating oxidized Met and deamidation products that coelute with another basic peak under the
same conditions.
As previously described

44

conventional HIC may not be efficient enough to separate

positional isomers at protein level. However, HIC under low salt concentration with online MS
compatibility may extend capabilities to monitor isomerization.

30

1.4 Commercially Available HIC Columns to Characterize Antibodies and
Related Molecules
HIC is a growing separation technique to separate biological molecules and only limited
number of columns with different matrices are available to achieve adequate separation.
Columns with solid phase description including known applications are indicated in Table 1.2.
Below are the commercially available columns for conventional HIC chromatography 66.
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Table 1.2. HIC-HPLC Columns and Analytical Applications for mAbs and related molecules 66.
Column

Solid phase

Particle/pore size

Application

Dionex Propac

proprietary ethyl/amide
based chemistry on nonendcaped silica

5 μm, 300Å pore size

Trp oxidation, Asp
isomerization, succinimide in
mAbs, Carboxy terminus
processing in Fc, serine Ofucosylation

TSKgel butyl-NPR

butyl on polymethacrylate
base material

2.5 μm, (non-porous)

TSKgel
phenyl- 5PW

phenyl on
polymethacrylate base
material
poly ethyl ether on
polymethacrylatebase
material
Spherical, highly crosslinked PS/DVB

10 μm, 1000Å pore
size

Proteolytic cleavage
aggregates, misfolded
domains.
Asp isomerization in mAbs,
Fab N-glycosylation, free thiol
in Fab
(Fab)2 purification, Antibody
drug conjugates

Hydrophilic polymerbased
Phenyl on
polystyrenedivinylbenzene
particles
ethyl/aspartamide on silica

5 μm non Porous

TSKgel ether-5PW
Sepax Proteomix HIC Butyl
MAbPac HIC-Butyl
POROS P2/20
PolyLC ethyl Aspartamide
PolyLC methyl Aspartamide
PolyLC propyl Aspartamide
PolyLC butyl Aspartamide
PolyLC pentyl Aspartamide

10 μm, 1000Å pore
size
1.7, 5 and 10 μm,
non-porous

Proteins, mAbs, ADCs,
oligonucleotides and
peptides
mAbs and ADCs

20 μm, 500–10000Å
pore size

Preparative applications

methyl/aspartamide on
silica
propyl/aspartamide on
silica

5 μm, 1000Å pore
size
5 μm, 1000Å pore
Size
5 μm, 1000Å pore
size

propyl/aspartamide on
silica
propyl/aspartamide on
silica

2 and 3 μm, 1000Å
and 1500 Å pore size
2 and 3 μm, 1000Å
and 1500 Å pore size

Antibodies, polypeptides and
proteins
Isolation of integral membrane
proteins and their complexes
Antibodies, Antibody minor
variants, polypeptides and
proteins
Antibodies
Antibodies and proteins

(Adopted with the permission of Taylor & Francis)
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1.5 Theoretical Aspects of HIC
Since RPLC technique operates under protein denaturing conditions such as mobile phase
with acidic additive, high percentages of organic modifier, elevated temperatures and stationary
phases with high hydrophobicity, it is very difficult to separate the biomolecules with minor
hydrophobicity differences. In those circumstances, HIC will be a valuable tool

72

where it can

separate molecules with very minor differences in overall hydrophobicity and significant
difference in surface hydrophobicity. In 1948, for the first time Tiselius

73

described the

separation concept of HIC based on the protein salting-out principle. Later on, in 1973 Hjertén
called this mode of separation hydrophobic interaction chromatography

67

. Due to the unique

characteristic nature of this technique, HIC gained a significant interest in the industry. In 2016,
Fekete

74

clearly showed in Figure. 1.7, the difference in chromatographic profiles of a reduced

mAb obtained by both RP and HIC. In HIC, the original “Y” shape of the mAb is maintained
even after the disulphide bridges have been reduced. Whereas in RPLC, the heavy- and light
chains (Hc, Lc) are well separated.
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Figure 1.7. Analyzing intact and reduced mAb (adalimumab) in RPLC and HIC 74
(Adopted with the permission from Elsevier)
HIC retention model is a complex mechanism because multiple gradients play a role in the
separation. Throughout past few decades, there have been many fundamental studies which led
to the different retention models and various theories such as hydrophobic interaction,
hydrophobic effects, solvophobic theory, salting-out effect and dehydration of proteins to explain
the retention in HIC. Based on these theories and experimental results it was clear that protein
retention in HIC is driven by multiple parameters.

1.5.1 Salting-out effect
The concept of protein chromatography is based on hydrophobic interactions. In protein
chromatography, the mobile phases are salt solutions, so Tiselius used the term “salting-out
chromatography”. A salting-out effect is the interaction of mobile phase – protein in HIC, which
means nonelectrolyte proteins become less soluble in an electrolyte mobile phase which is in
34

high salt concentration. In aqueous solutions, proteins fold and the hydrophobic amino acids
form protected hydrophobic areas, whereas hydrophilic amino acids interact with the
surrounding water molecules to form hydrogen bonds. If the hydrophilic surface of the protein is
large enough, then the protein can be dissolved in water. When salts are added to the solution,
most of the water molecules will solvate salt ions and the number of water molecules available to
interact with the hydrophilic amino acids will decrease. As a result, the protein–protein
intermolecular interactions become stronger due to the decreased amount of surrounding water
molecules. In the end, the protein molecules can self-associate (aggregate) by forming
hydrophobic interactions with each other

74

. Because the separation is highly dependent on salt

gradient, this mode separation was also called “salt mediated separations of proteins”. In 1986,
Porath proposed that it be called “salt-promoted adsorption” or “salt-promoted adsorption
chromatography (SPAC)” as alternative names for HIC 75.

1.5.2 Hydrophobic effects, formation of cavity
In general, a hydrophobic effect is defined as the tendency of nonpolar molecules to
self‐associate in water rather than to dissolve individually. Hydrophobicity is defined as the
repulsion between a non-polar moiety of the protein and of the polar environment such as water
63

. This effect is responsible for the low solubility of proteins

75-76

. On the same token, the term

“hydrophobic interactions” is frequently used to describe the forces resulting in the association
of nonpolar molecules or the binding of hydrophobic moieties in aqueous solutions. When
biomolecules dissolve in aqueous system, water cannot make hydrogen bonds with nonpolar
moieties of the protein. Due to that reason, the neighboring water molecules get separated from
each other to form a cavity for the protein

77

. This process requires energy. On the other hand,
35

when two or more molecules come closer, they are associated with hydrophobic interactions. As
a result, their hydrophobic contact surface area is reduced and energy is released (exothermic).
The amount of energy is proportional to the size of the hydrophobic contact surface area of the
protein. In other words, the aggregation or (self-association) in aqueous solutions is a
spontaneous process and is mainly driven by the entropy change

77-80

. The orientation of the

water molecules at the cavity around the non-polar protein molecule will lead to a large entropic
effect

81-82

. Sturtevant and Livingstone later demonstrated that the heat capacity change in

transfer-into-water processes is driven by the change in the water-accessible non-polar surface
area of the molecule

74, 83-84

. Overall, hydrophobic interactions not only involve entropic effects

but are entropy driven at low temperatures, and enthalpy driven at elevated temperatures, when
the heat capacity change remains constant in the range of experimental temperature 85.

1.5.3 Solvophobic theory
The solvophobic theory explains the interactions between polar solvents (aqueous mobile
phase) and less or non-polar solutes (protein). In polar solvents, strong cohesive forces are
present between the solvent molecules due to hydrogen bonding and other polar interactions
provide a strongly structured order. Therefore, less polar solutes tend to be insoluble because
these strong solvent–solvent binding interactions must be overcome to make bonds with polar
solvents. According to this theory, the solute molecules adsorb to the surface of the stationary
phase as a result of their rejection from the polar solvent and their attraction for the hydrophobic
stationary phase

86

. This seems to be the mechanism for the molecule retention in liquid

chromatography, in general. Horváth et al. used solvophobic theory to explain the basis of
retention mechanisms in RPLC 87.
36

1.6 Principle of HIC
Hydrophobic proteins will self-associate (aggregate) or interact with each other when they
dissolve in aqueous solutions. This interaction between the molecules can result in various
biological interactions, such as protein folding, protein-substrate interactions, etc. HIC is used in
both analytical and protein purification application to characterize biomolecules. The basic
principle of HIC is hydrophobic regions in large molecules bind to hydrophobic alkyl chains of
the stationary phase. These interactions occur in an environment which helps hydrophobic
interactions, such as high salt solutions 68.
In general, water (a polar solvent) is a poor solvent for nonpolar molecules. Therefore, in
pure water, proteins will self-associate or aggregate, in order to achieve a state of lowest
thermodynamic energy. Prior to self-association, water molecules form highly ordered
structures around each individual macromolecule (Figure 1.7). The self-association of nonpolar
molecules (such as proteins) in the polar solvent is driven by a net increase in entropy of the
environment. During the aggregation process, the overall surface area of hydrophobic sites of
the protein exposed to the polar solvent is decreased, resulting in a less structured (higher
entropy) condition, which is the favored thermodynamic state.

37

Figure 1.8. HIC separation mechanism (1) Biomolecule (2) Alkyl chain on the base matrix (A)
Ordered water molecules around the hydrophobic patches of the biomolecule in low salt
conditions (B) Disrupted water shell and biomolecule-stationary phase interactions in high salt
conditions
HIC separations result from interactions between hydrophobic patches of proteins and
low-density and moderately hydrophobic alkyl chain
has a base matrix of silica or polymethacrylate

88

89-90

attached to the stationary phase, which

. In conventional HIC, the separation is

performed using buffer systems by applying a linear salt gradient starting at a relatively high salt
concentration

91

. In highly concentrated salt solutions (mobile phase A), proteins lose their

hydrated shell and as a result hydrophobic patches will be exposed. These hydrophobic moieties
will be adsorbed by the hydrophobic surface of the resin causing retention on the stationary
phase. For protein elution to occur, an aqueous solvent (mobile phase B) containing no or low
salt concentration is used. This low salt mobile phase will help to reassemble the water shell and
enable the elution of the proteins from the column based on the surface hydrophobicity (Figure
1.8). Therefore, the elution order enables ranking of the proteins on the basis of their surface
hydrophobicity, with high recovery and high sensitivity to conformational variations 63.
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1.7 Theory
HIC

67, 92-94

chromatography is an established and powerful analytical tool

95

for separating

biomolecules. The retention in HIC is mainly driven by the hydrophobic interactions between
amino acid residues of the proteins and the alkyl chains or other non-polar functional groups
located at the surface of the stationary phase

67, 76

. In HIC, retention is mainly affected by the

biomolecule’s surface hydrophobicity 63-64, 96-98.
A commonly used salt concentration as the starting condition in conventional HIC is in
between 1 M of ammonium sulphate of ammonium phosphate and around 5.5 M ammonium
acetate. The selected concentration of a salt will depend upon the lyotropic strength of the salt,
the solubility of a biomolecule in the salt solution and the nature of stationary phase used in the
separation 87, 99-101. The influence of salt type plays a major role in hydrophobic interaction. The
lyotropic strength of salts follow Hofmeister series (Figure 1.9) for the precipitation of
biomolecules 102. The salts that are typically used in the HIC methodology are sulfate, phosphate
or citrate salts which are at a high lyotropic strength in the Hofmeister series 63. Unfortunately,
these salts are not compatible with MS analysis

47

. As an alternative, a volatile salt such as

ammonium acetate can be used and is proven to reduce nonspecific sodium adducts

103-104

.

According to the Hofmeister series ranking order, ammonium acetate is not a strong kosmotropic
salt and acetate ions are at a low position of the series 63. It cannot promote strong hydrophobic
interactions by completely disrupting hydration shell around the biomolecule to enhance proteinsurface interactions. While acetate allows for compatibility with MS 105, it was proven to provide
inadequate retention when used with conventional HIC materials 106 which are mostly made with
butyl alkyl chains and PolyPROPYL A

105

stationary phases. In the presence of ammonium

acetate, a stationary phase which has alkyl chain length longer than butyl stationary phase may
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be required to interact with amino acid residues of the mixture of biomolecules for an adequate
retention. In 1986, Gooding et al. proved that HIC column with pentyl alkyl chains gave
adequate retention of proteins with 4 M ammonium acetate 104.

Figure 1.9. Hofmeister series with lyotropic strength
HIC columns are less retentive compared to RPLC columns. The reason for this is that
the stationary phases which are used in HIC are low-density and moderately hydrophobic ligands
such as butyl, phenyl or ether, and are attached to a hydrophilic under layer such as silica or
polymeric material

88-90

. Because these columns have low bonding density, the strength of

retentivity between biomolecules and the alkyl chains can be controlled

68

. These weakly

hydrophobic ligands interact with a limited set of hydrophobic residues on the surface of the
molecule’s tertiary structure. With the above chromatographic conditions, usually biomolecules
elute in the order of increasing hydrophobicity, generally with high recovery and high sensitivity
to conformational variations

63

. In this technique, although molecule size may contribute to

retention mechanism, surface hydrophobicity and bonding density of alkyl chains determine
retention

64

. Since high concentrated salt solutions are used in HIC, there are very minimal

secondary interactions, unlike RPLC

107

. Therefore, the elution order enables ranking of the

biomolecules on the basis of their relative hydrophobicity 107.
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The retention mechanism of HIC methodology can be altered by adding a small portion
of organic modifiers. It has often proven as an advantageous parameter in HIC method
development for decreasing the retention of highly hydrophobic compounds and also to adjust
selectivity

89, 107-108

. Maintaining all of the mobile phase conditions of conventional HIC and

adopting the use of an organic modifier such as acetonitrile from RPLC, hybrid mode of HIC
(HHIC) (Figure 1.10) methodology enhances the ability to decrease the retention time of
adsorbed solutes on HIC stationary phases. Organic solvents will help to weaken the proteinstationary phase interactions leading to a decrease in the retention time
proved that this approach increases the recovery of biomolecules

107, 110

107, 109

. Fekete et al.

and also allows for the

separation to be tuned while maintaining biomolecules native conformation 49, 107, 110.

Figure 1.10. Hybrid HIC combines elements of two major chromatographic methods (RPLC and
HIC)
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Although conventional and Hybrid HIC compliments other chromatographic techniques,
it has challenges, such as use of mobile phases with high concentrations of sulfate and phosphate
salts

111

. As these are non-volatile salts 63, they prevent online coupling with mass spectrometry

(MS). However, volatile salts such as ammonium acetate can be used but in higher
concentrations. To overcome this limitation and to potentially provide an alternate selectivity, in
2016, Alpert used poly (alkyl aspartamide) silica HIC stationary phases that he synthesized by
derivatizing short polymers such as anhydropoly(aspartic acid), or poly(succinamide) (Figure
1.11) 112 88 to develop a series of more-hydrophobic HIC materials.

1.8 Preparation of Poly (alkyl aspartamide) Silica
The following sections will describe the synthesis of poly (alkyl aspartamide) silica
stationary phases which will provide an option of using lower concentrations of volatile salts
with an online MS compatibility.

1.8.1 Preparation of poly (succinamide)
Various studies showed the advantages of using short polymers to prepare coatings for
inorganic chromatography supports 113. The coatings that are made with these polymers converts
an inorganic support into a cation-exchange material suitable for protein chromatography. The
reactive polymer is anhydropoly (aspartic acid), or poly (succinimide) which is formed in almost
quantitative yield by heating aspartic acid under conditions which causes it to condense (Scheme
1)

80-84

. poly-α, β-D and L-aspartic acid

81-82

were produced from subsequent hydrolysis steps.

Poly (succinimide) could be used to prepare a variety of chromatographic media in addition to
the cation exchanger.
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Figure 1.11. Preparation of Poly (Succinamide) from Aspartic Acid 112
(Adopted with permission from Elsevier)

1.8.2 Preparation of aminopropyl-silica
Aminopropyl-silica

was

prepared

by

mixing

vydac

silica

with

3-

aminopropyltriethoxysilane in toluene. After a step by step process, in a few hours the product
was collected and washed well with toluene and acetone, then dried by continued suction.

1.8.3 Preparation of poly (succinimide)-silica
The dried aminopropyl-silica was swirled and degassed using poly (succinamide) in
DMF. After 24 hours of swirling at room temperature the product was collected and washed well
with DMF ad acetone to obtain poly (succinamide)-silica. Then above prepared poly
(succinamide)-silica was swirled and degassed in a mixture of DMF and containing β-alanine
and trimethylamine. After 24h of occasional swirling, washing well with HCl, water and acetone
and going through the drying process, the poly (aspartic acid)-silica will be ready. The coating is
simple and is easy to prepare reproducibly. The columns packed with this material showed very
good performance in capacity, selectivity, recovery of enzyme activity and peak shape.
Due to its reactivity, poly (succinimide)-silica can be used to make various derivatives
other than poly (aspartic acid)-silica. These derivatives can be used for steric exclusion
43

chromatography and various ligands could be added to the poly (succinimide) coating for use in
affinity chromatography.

Figure 1.12. Reaction scheme for the preparation of poly (Aspartic acid) silica 112
(Adopted with permission from Elsevier)
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1.8.4 Preparation of poly (alkyl aspartamide)-silica
Poly

(succinimide)-silica

was

weighed

into

a

flask

and

swirled

in

N,N-

dimethylformamide (DMF). With continuous swirling alkylamine was added along with DMF.
The resulting mixture was left for 24 h at room temperature with frequent swirling during the
first 2 h and occasional swirling thereafter. The product was collected in a medium-porosity
sintered-glass funnel and washed well with water, then hydrochloric acid, water, and acetone,
and finally dried by continued suction to obtain poIy(alkyl aspartamide)-silica 88.

Figure 1.13. Reaction scheme for the preparation of poly (propyl aspartamide) silica 88
(Adopted with permission from Elsevier)
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PolyPROPYL A and PolyETHYL A materials were synthesized and both cationexchange capacity

112

and hydrophobic-interaction binding/release (HIB/R) capacity was

estimated using hemoglobin 64. The results proven the capacity of materials is very high.

Figure 1.14. The reaction of Poly(succinimide)-silica with n-propyl amine 88
(Adopted with permission from Elsevier)

Experiments were carried out to study the protein recovery of PolyPROPYL A and
PolyETHYL A columns and in general greater than 90% recovery was observed. The data also
demonstrated that most of the molecules eluted with preservation of full activity with some
exceptions. Later it was confirmed that it was due to higher ionic strength of the medium in
which molecule was unstable. Research also showed that addition of detergents in the mobile
phase not only may help with lower recoveries but may also increase selectivity

114

. These

columns were also evaluated for estimating the retention characteristics and conformational
46

lability. The experimental results indicated that for some proteins there were very broad peaks or
some scenarios multiple peaks were observed.
Stationary phases with these coatings demonstrated a wide range of hydrophobic properties
and it was observed that proteins are generally eluted as sharp peaks with good recovery

88

.

Using these columns, the native and denatured forms of biomolecules can be resolved if
conformation change is slower than the migration time through the column

115-119

, otherwise, a

single broad peak can be expected, which is the weighted average of different conformations
which are in the equilibrium
forces are involved

122-123

117, 119-121

. Historically it was proven that in HIC Van der Waals

which will operate in a much shorter range than the range in

electrostatic effects. This suggests that unlike ion-exchange, the access of the adsorption on the
stationary phase to adsorption sites on a protein surface will be more sensitive to conformational
differences in HIC. Therefore, protein with different conformations will have different binding
affinity in HIC, and protein peaks in HIC usually elute as broader peaks compared to ion
exchange. The same observation was made by Alpert in his research, as well 88. Based on various
experiments Alpert indicated that these poly (alkyl aspartamide) coatings of silica capacity is
very high and can be used for preparative chromatography 88.
In 2016, Alpert

49

used poly (aspartamide) silica to make new stationary phases with

longer alkyl chains such as Pentyl, Hexyl up to Decyl. To enhance the capabilities of these
stationary phases, Chen evaluated 49 the performance of ammonium acetate with columns of the
existing HIC materials PolyPROPYL A and PolyBUTYL A to estimate the concentration of
ammonium acetate necessary for the retention of small proteins and to assess the effect of alkyl
chain length. Through the experiments he demonstrated that these can retain the native structure
of biomolecules using MS compatible concentrations of ammonium acetate 49 and elute as intact
47

proteins in hybrid mode using ammonium acetate concentration of 1 M or less. This salt
concentration has previously been demonstrated to be compatible with mass spectrometry
analysis

124

. He also confirmed the new HIC materials can function as a hybrid form of

conventional HIC and RPLC 49. In addition, he observed that with the new HIC materials some
organic solvent is required in the mobile phase used in a gradient for the elution of proteins in a
reasonable time frame

49, 89, 107, 110

. These columns are proven to offer high sensitivity, better

speed and selectivity to simultaneously detect, identify and quantitate molecules in a complex
mixture based on their mass-to-charge (m/z) ratio. Recent literature

49, 125-126

demonstrated that

HIC technique also helps to confidently characterize unknown compounds and confirm trace
components at the lowest possible levels.

1.9 Area of Interest
Commercially available HIC columns use either non-volatile mobile phases or high
concentration of volatile mobile phases. Such salts are not compatible to use with online MS
because they can cause a reduction in the vapor pressure and consequently a reduced signal.
They can be used with off-line MS but the desalting step is required before injecting the sample
onto LC/MS.
The purpose of this research was to study the chromatographic behavior of mAbs and
fusion protein on poly (alkyl aspartamide) silica columns using HIC on hybrid mode and
evaluate the impact of mobile phase components such as salt, pH and organic modifier. Extend
the study to estimate the influence of chromatographic parameters on the separation of mAbs
which helps to enhance the compatibility of online mass spectrometry. In addition, we intended
to estimate the influence of different hydrophobic alkyl chain strength in HHIC separation mode.
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The research also was intended to evaluate the effect of gradient time and linear flow velocity on
retention and efficiency of these columns.

1.10 Scope of the Research
Protein binding to HIC adsorbents is promoted by moderately high concentrations of
kosmotropic salts such as sulfate, phosphate, or citrate, which also have a stabilizing influence
on protein structure. Elution is achieved by a linear or stepwise decrease in the concentration of
salt in the adsorption buffer. Use of these specific salts in high concentrations is not compatible
with online Mass Spectrometry (MS) analysis. To make this technique compatible with online
MS, poly (alkyl-aspartamide) silica material with more hydrophobic stationary phases were
synthesized and characterized [10] to obtain adequate balance between retention and
denaturation with online MS compatible salts and their concentrations.
In earlier research, stationary phase alkyl chains such as butyl to decyl were synthesized
to increase the ability for protein to be retained on stationary phases consisting of poly (alkylaspartamide) silica. However, it was clearly demonstrated in literature that the selectivity and
retention on HIC material depends upon the properties of the biological molecules used in the
analysis and also on several other parameters, such as stationary phase type (backbone, alkyl
chain length and bonding density), salt concentration, buffer pH, temperature and mode of
operation.
In this research, selectivity and retention will be evaluated by studying the effect of salt
concentration, pH of the mobile phase and percentage of organic modifier. The selectivity of a
mixture of mAbs will be assessed using poly (alkyl-aspartamide) silica columns with different
alkyl chain lengths. Based on the experimental results, the working range of the parameters that
49

were studied to achieve acceptable retention while keeping the biomolecule in non-denatured
form will be discussed. This knowledge will help to enhance the scope of the utilization of HIC
on hybrid mode chromatography in mAbs separation.

1.11 Research Focus
This dissertation describes the factors impacting the separation of larger biomolecules
including mAbs and fusion protein on poly (alkyl aspartamide) silica columns and deconvolute
the impact of HHIC mobile phase components and different alkyl chain lengths of poly (alkyl
aspartamide) silica stationary phases. The research also explores the impact of resident time of a
biomolecule on the column in the presence of organic solvent. In addition, we evaluated the
impact of linear flow velocity and gradient time on chromatographic efficiency.
Chapter 2 provides the information about the need of an organic modifier using these
columns and the impact of the salt concentration on the separation. Experimental details will
help to understand the chromatographic parameters that influence the retention and selectivity.
This chapter also describes the impact of longer resident time of a biomolecule on the column in
the presence of organic solvent. Assessment of conformational changes in the presence of
moderate organic content using orthogonal methods such as intrinsic fluorescence and Mass
spectrometry is also discussed. In addition, the impact of linear flow velocity and gradient time
on chromatographic efficiency is presented. With these columns a small portion of organic
solvent is required to elute biomolecule from the column in a reasonable timeframe. Chapter 3
describes the organic solvents that can be used for the separation and the percentage that is
required to help in elution. This chapter also focuses on the effect of mobile phase pH, and the
role of temperature on separation using these columns.
50

In the literature it was clearly discussed that to obtain adequate retention using
ammonium acetate, greater than propyl alkyl chain is required. This fact indicates that alkyl
chain length has a great influence on retention. Chapter 4 describes the effect of alkyl chain
length on the selectivity and interdependencies of salt and the stationary phase. It will also assess
mobile phase components which can influence chromatographic parameters such as retention
and selectivity. Chapter 5 will summarize the research findings and provides a deep
understanding on chromatographic behavior of poly (alkyl aspartamide) silica columns using
hybrid HIC mobile phases.
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Chapter 2 : Hybrid Mode of Hydrophobic Interaction
Chromatography of Monoclonal Antibodies and Related
Biomolecules: Influence of Elution Conditions on Chromatographic
Performance Using Poly (alkyl aspartamide) Silica Columns
2.1 Introduction
Operating conditions and mobile phase properties such as ionic strength, pH and organic
modifier play a major role in hybrid HIC chromatographic retention 1-2. In a recent article 2, Chen
et al. demonstrated that adequate retention can be achieved with relatives low concentrations of
NH4OAc (~1M) with the poly (alkyl aspartamide) stationary phases using small model proteins.
In addition they observed that some organic solvent such as acetonitrile is required to elute the
proteins in a reasonable time frame

2-5

.

The similar observations with other HIC

chromatographic systems has been previously reported

6-8

. The purpose of our research was to

understand the factors impacting the separation of larger biomolecules including mAbs and
fusion protein on poly (alkyl aspartamide) silica columns and ascertain the impact of salt and
organic modifier in HHIC mobile phases. The research was also intended to explore the impact
of longer resident time of a biomolecule on the column in the presence of organic solvent. In
addition, we evaluated the impact of linear flow velocity and gradient time on chromatographic
efficiency.

2.2 Experimental Details
HPLC grade water and MeCN (acetonitrile) were used in all analysis. NH4OAc
(ammonium acetate) solution was purchased from Teknova, Hollister, CA. MeCN was purchased
from Sigma-Aldrich and 0.1 N NH4OH solution was purchased from Ricca Chemicals. HIC
columns, with various stationary phases such as PolyPROPYL A, PolyBUTYL A, PolyPENTYL
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A, PolyHEXYL A, and PolyHEPTYL A with dimensions of 50 x 2.1 mm, 3µm particles with a
pore size of 1000 Å were obtained from PolyLC INC, Columbia, MD. Chromatographic
separations were performed using Waters Acquity H-class HPLC system with a flow rate of 1.0
mL/min at 25°C and detection by UV absorbance at 280 nm. (PolyPENTYL A column with
dimensions of 50 x 2.1 mm, 3µm particles with a pore size of 1000 Å gave about 4800 psi
pressure.) HPLC grade water was used to prepare mAb samples at 1 mg/mL. Molecules that
were used in this experimental work were monoclonal antibodies (mAb) and a fusion protein.
Biomolecule 1, 4 and 5 were IgG1s and biomolecule 2 was IgG4, biomolecule 3 was NIST
(National Institute of Standards and Technology) mAb and biomolecule 6 was IgG4 fc fusion
protein. Except NIST mAb, all other biomolecules were kindly provided by Bristol Myers
Squibb (BMS) a Biopharmaceutical Company, New Brunswick, NJ and the names of the
molecules cannot be revealed. In this dissertation, except NIST mAb, all other mAbs will be
referenced as biomolecules. Unless otherwise specified chromatographic separations were
performed at 25°C with initial 0.5 minutes hold and a 10 min linear gradient going 100% mobile
phase A to 100% mobile phase B. 1 M NH4OAc was used as mobile phase A and 20mM
NH4OAc (overall) with 50% MeCN as mobile phase B. pH was measured for aqueous mobile
phases before combining organic solvent. For convenience NH4OAc will be referenced as “salt”
in the results and discussion sections. Intrinsic fluorescence spectra was collected from 210-400
and ratio was measured using 330 nm and 350 nm. Mass spectra were acquired using a Waters
QToF Premier instrument operated in positive electrospray mode using a cone voltage of 40,
desolvation temperature of either 250 or 450°C, and an ion source temperature of 150°C.
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2.3 Results and Discussion
To understand the chromatographic parameters that influence the retention and selectivity of
large proteins under hybrid HIC conditions, the effect of mobile phase ionic strength, pH and
organic modifier content was studied on a mixture of six biomolecules. A Poly PENTYL A
column was selected for this research after a brief evaluation of available stationary phases
(PolyPROPYL A, PolyBUTYL A, PolyHEXYL A and PolyHEPTYL A). This column was
found to be most suitable based on an evaluation of retention, peak shape and analyte recovery
for the separation of selected mAbs which is in agreement with a recent report 9. The separation
was performed using gradient elution in which mobile phase A and mobile phase B with and
without 50% MeCN (Figure 2.1). Under conditions 4 and 5 (which differ by a slight change in
mobile phase pH) all biomolecules eluted under the influence of the dual opposing gradients of
decreasing NH4OAc concentration and increasing MeCN concentration. A very good separation
was achieved for all six biomolecules using this broad linear gradient. Without any further
optimization this technique demonstrated the ability to separate mixture of components some of
which have a high degree of sequence homology. It should also be noted that these components
were not screened for favorable chromatographic behavior prior to their inclusion in this study.
Typically, under conventional HIC operating conditions, low salt concentration will promote
elution. However, in this study it was found that when an NH4OAc gradient was employed with
no MeCN in mobile phase B with PolyPENTYL A column (Figure 2.1 conditions 2 and 3), the
partial elution of only the two least retained (more hydrophilic) biomolecules was achieved and
no elution was observed with hydrophobic biomolecules even when pure water was used as
mobile phase B in place of 20 mM NH4OAc (Refer to Section 3.4). In order to achieve adequate
elution, inclusion of some MeCN in the mobile phase B was required, which was consistent with
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previous findings for the separation of smaller proteins 2. This result demonstrates even small
amounts of MeCN can dramatically effect elution. For example, biomolecule 1 elutes at ~ 1.5
minutes under conditions 4 and 5 in Figure 2.1, which corresponds to MeCN concentration of ~
2%. Nevertheless, when mobile phase B without MeCN was used retention increased and
chromatographic efficiency was greatly reduced.

Figure 2.1. Impact of organic modifier on elution using a PolyPENTYL column at 25°C; MP A:
1M NH4OAc and MP B: 20 mM NH4OAc with and without organic; Sample is a mixture of 6
biomolecules; 1) MilliQ water blank using MP A and MP B: 20 mM NH4OAc with 50% MeCN
(aqueous pH@7.0); 2) Sample analysis using MP A and MP B: 20 mM NH4OAc no pH
adjustment and no MeCN; 3) Sample analysis using MP A @7.0 and MP B: 20 mM NH4OAc pH
@7.0 no MeCN; 4) Sample analysis using MP A and MP B: 20 mM NH4OAc with 50% MeCN no
pH adjustment; 5) Sample analysis using MP A @pH7.0 and MP B: 20 mM NH4OAc with 50%
MeCN (aqueous pH@7.0)

2.3.1 Effect of salt concentration on selectivity
In general, in HIC chromatography when there is an increase in salt concentration the
retention of the biomolecule increases. Based on the previous set of experiments, it is apparent
that the slight modifications to the mobile phase had a significant influence on the retention
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behavior of the biomolecules studied. To evaluate the effect of salt, we ran a series of
experiments (Figure 2.2 and 2.3) by varying NH4OAc concentration in mobile phase A from 0.5
M to 2.5 M while all other parameters were kept constant. In these experiments, peak 1 retained
longer with an increase in the salt concentration, which is an expected conventional HIC
retention behavior. As the concentration increased from 1M and above, peaks 1, 2 and 3
exhibited a fairly linear increase in retention. However, an interesting behavior was observed for
peak 4, 5 and 6, where the greatest retention occurred at the lowest salt concentration (0.5 M)
which is a non-typical HIC retention pattern. Overall, peaks 4, 5 and 6 followed a similar pattern
by eluting faster with increasing salt concentration. However, there was a slight decrease in the
retention of peak 6 compared to peak 4 and 5. The retention of peak 2 showed the most complex
relationship to the change in the salt concentration of mobile phase A was to widen the
separation window by decreasing retention of the earlier eluting components and by increasing
retention of the late eluting components. From a practical perspective it is apparent that the salt
concentration of mobile phase A is a useful parameter to increase chromatographic resolution
and the overall peak capacity of a separation of the large biomolecules used for this study. The
improved separation of these large biomolecules at salt concentrations less than 1 M is a key
difference compared to the separation of small proteins, which were reported to be poorly
behaved under similar conditions which was attributed to conformational instability 2. One
measure of protein conformational stability is their thermal transition temperatures.

For

example, the melting temperature of α chymotrypsinogen A used in an earlier investigation of
hybrid HIC is approximately 50°C at pH 7
mAb is typically in the range of 65-70°C

10

11

, whereas, the thermal transition of a therapeutic

indicative of higher conformational stability. In
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addition to improving peak capacity, mobile phases with lower NH4OAc concentration generally
provide an increase in analyte response by ESI mass spectrometry 12.
This observed increase in retention as the salt concentration of mobile phase A decreased
suggests that there could be more than one mechanism of retention. While the observed greater
retention at the reduced salt condition is consistent with ionic interactions with the stationary
phase, the poly (alkyl aspartimide) stationary phase is reported to have a very low ion exchange
capacity

13

. It is also important to recognize that even at the lowest salt concentration (0.5M)

used in this study, there is likely more than sufficient ionic strength to suppress ionic interactions
with the stationary phase. Additionally, if ion exchange was occurring it would likely be
manifested by distortion of the chromatographic peaks, which was not observed.
We also investigated the possibility that the increase in the retention under low salt
conditions was due to the increase in the hydrophobicity of the biomolecule resulting from
conformational changes. In general, a denatured or partially unfolded molecule has longer
retention compared to a native conformation due to exposure of previously buried hydrophobic
residues. If there is any denaturation due to the organic solvent then a change in the retention
time is expected. Examining the results from the experiment (Figure 2.5), which was conducted
for the purpose of understanding the effect of flow rate on chromatographic efficiency, it is
possible to gather some information on kinetics of molecular unfolding in the presence of an
organic solvent. In this experiment, the gradient time and flow rate were proportionally adjusted
to maintain a constant gradient volume. The result was that each component eluted under
identical mobile phase conditions despite retention times varying by a factor of 10. If protein
unfolding were occurring on the time scale of the chromatographic experiment, it is expected
that the retention volume would increase with increasing time on column. While it is widely
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assumed that conformational changes are instantaneous, as described by Sethuram’s et. al.,
conformational changes in the presence of hydrophobic surface can be faster (less than a minute)
or slower (up to 1200 minutes)

14

. Since no shifts in retention volume were observed (Figure

2.5), it can be concluded that under the conditions of 1 M NH4OAc, if protein unfolding is
occurring it is proceeding either much faster or slower than the chromatographic time scale as
observed by Chen et al 2, 9.
To further evaluate conformational changes in low salt solutions, intrinsic fluorescence
experiments were carried out with 0.5 M and 1M NH4OAc mobile phases using biomolecule 6
(fusion protein) to compare the ratio of tryptophan fluorescence emission at 330 nm and 350 nm
15-16

. Biomolecule 6 was selected for this study because it is the latest eluting component and

therefore exposed to greatest MeCN concentration. A mobile phase containing 0.5 M NH4OAc
was selected because it gave longest retention time and 1M was the suitable control yielding
retention time similar to the higher salt concentration mobile phases. The data showed that there
was no change in the ratio (Table 2.1), which indicated that there were no significant
conformational changes to the biomolecule in the regions where there are tryptophan residues.
To further evaluate conformational changes we also conducted electrospray mass spectrometry
experiments using the same chromatographic conditions that were used for intrinsic
fluorescence. It was reported that the appearance of electrospray mass spectra of a protein under
hybrid HIC conditions is similar to the spectra that was obtained in folded form rather than
denatured form 2. The ESI desolvation temperature was optimized to generate mass spectra
where the charge state distribution is centered at high m/z which is consistent with native or near
native protein structure.

For comparison, we also collected mass spectra at much higher

desolvation temperature to produce a spectrum of the denatured protein where the charge state
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distribution centered at significantly lower m/z. Under the non-denaturing MS conditions, a
statistical significant difference in the charge state distribution was observed between the 0.5M
and 1M conditions. However, the minor changes to the average change state distribution that
were observed (Figure 2.4) were may be due to the differences in the solvent conditions used.
This data may not be sufficient enough to conclude that it is due to conformational changes. For
example, the change in charge state distribution may be due to the impact of the change in salt
concentration on the electrospray ionization process rather than conformation. It has been well
established that mobile phase variations can lead to minor changes in the appearance of the mass
spectra. For example, in a recent article by Ding 17, it was reported that the addition of a small
percentage of a basic additive to the mobile phase can act as a charge stripping agent and
significantly alter the charge state distribution.

Table 2.1. Impact of Mobile Phase Salt Concentration on Biomolecule 6
Intrinsic fluorescence
Salt Concentration

330 nm

350 nm

Ratio of 330 nm /350 nm

Max Absorbance (eu)
1.0 M 1

9192.9

9182.5

1.001

0.5 M 2

5345.6

5339.6

1.001

2.5 M 3

10131.6

10156.2

0.998

Table 2.1. Impact of mobile phase salt concentration on mAb 6 conformation. 1) MP A: 1M
NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with 50% ACN at pH 7.0, 2) MP A: 0.5 M
NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with 50% ACN at pH 7.0, 3) MP A: 2.5 M
NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with 50% ACN at pH 7.0). Flow rate 1 mL/min.
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Even though these non-chromatographic experiments provided some basic information
about conformation changes under HHIC chromatographic conditions, more techniques such as
Circular Dichroism and protein NMR are required to gather details to confirm the structural
changes in a biomolecule. Despite the inconclusive findings related to conformational change,
the ESI experiments did provide a useful demonstration of the improved signal intensity that
results from conducting analyses at lower NH4OAc concentration. The spectral intensity of the
most abundant charge state increased by approximately a factor of five with the use of 0.5 M
NH4OAc compared to 1 M (Figure 2.4).
Considered together, the results from the analyses by intrinsic fluorescence and ESI mass
spectrometry suggest that extensive protein unfolding has not occurred or that it only occurs
when the biomolecule is in the presence of the hydrophobic stationary phase

18-19

.

If the

biomolecules rapidly assume a folded conformational state after elution, the ability to detect the
changes by solution analysis would be confounded. A possibly more likely explanation of the
results from conformational analysis is that the changes are too subtle for detection by either
fluorescence or ESI mass spectrometry but never the less significantly impact chromatographic
retention. A final possible explanation for the enhanced retention under low salt conditions is
hydrophobic affinity effect

18, 20

. Unfortunately, a mechanism for hydrophobic affinity has not

been determined. It is possibly a distinct mechanism from HIC but it is also may be the same
phenomenon of increased retention under low salt conditions resulting from protein unfolding.
While the precise mechanism for increased retention of later eluting components under
low NH4OAc conditions is not fully understood, the benefits of operating under these conditions
include a widening of the elution window and the previously described enhanced response by
ESI mass spectrometry. It does appear however, that the NH4OAc concentration should be
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tailored to the precise requirement of the intended separation. For example if the requirement is
to separate and quantitate only components 4 and 5, a higher salt concentration would provide
better resolution despite the overall narrowing of the elution window observed for the separation
of this six component mixture. The behavior clearly demonstrates that the retention is not only
dependent on the salt concentration but also highly dependent on the hydrophilic and
hydrophobic nature of the individual biomolecule 21-24.

Figure 2.2. Impact of salt concentration on the selectivity (MP A: different concentrations of
NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with 50% MeCN with an aqueous pH 7.0); Peaks
1 through 6 are biomolecules used as a sample mixture.
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Figure 2.3. Impact of salt concentration on retention (MP A: different concentrations of
NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with 50% ACN at pH 7.0)
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Figure 2.4. ESI-MS conducted using mobile phase A with either 1 M or 0.5 M NH4OAc and
mobile phase B consisting of 20 mM NH4OAc with 50% MeCN, a) Desolvation temperature 450
°C, MP A: 1M NH4OAc, b) Desolvation temperature 250 °C, MP A: 0.5 M NH4OAc, c)
Desolvation temperature 250 °C, MP A: 1.0 M NH4OAc

2.3.2 Role of linear velocity on the separation
Another parameter that plays a major role in the overall separation is mobile phase linear
velocity. It not only has a significant influence on the efficiency, but also impacts the speed of
the analysis. To understand the effect of linear velocity on chromatographic efficiency and
resolution, mobile phase flow rates of 1, 0.8, 0.5 and 0.1 mL/min were evaluated (Figure 2.5).
Gradient run time was adjusted to maintain a constant gradient volume. Based on experimental
results, it was observed that when the flow rate decreased from 1 to 0.1 mL/min, there was
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approximately a 30% increase in the peak capacity (Figure 2.6). In addition, there were no
significant change in the selectivity and a moderate increase in the resolution at the cost of a
longer run time. The modest impact of linear velocity on peak capacity is somewhat surprising
since the expectation is that large molecules will exhibit poor mass transfer resulting in a more
significant loss of efficiency as linear velocity increases. Even though lower flow rates may
offer an increase in the peak capacity and provide enhanced resolution, a possible concern is that
a longer run time with extended exposure to organic solvent may affect the conformation of the
biomolecules. As described previously unfolding could lead to an increase in the hydrophobic
interactions with the stationary phase and results in longer retention times, or in the case of these
experiments, longer retention volumes (retention time multiplied by flow rate). However, as
shown in Figure 2.5, decreasing linear velocity and increasing run time from 10 minutes to 60
minutes did not impact retention volumes suggesting no change to molecular conformation due
to the longer exposure to the organic solvent. Additional experiments using biophysical
characterization techniques will provide more details to confirm the structural changes.
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Figure 2.5. Impact of flow rate on relative retention time (MP A: 1M NH4OAc at pH 7.0 and MP
B: 20 mM NH4OAc with 50% MeCN with an aqueous pH 7.0); Flow rates were 0.1, 0.5, 0.8 and
1 mL/min.
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Figure 2.6. Impact of linear velocity on peak capacity (MP A: 1M NH4OAc at pH 7.0 and MP B:
20 mM NH4OAc with 50% MeCN with an aqueous pH 7.0). Linear velocities were 173, 866,
1385 and 1732 cm/h with flow rates of 0.1, 0.5, 0.8 and 1 mL/min respectively. Peak capacity
was calculated using equation: 1+ (Gradient Time/Average peak width@50%peak height)

2.3.3 Gradient steepness
Chromatographic peak capacity is also strongly influenced by gradient steepness. The
effect of gradient steepness was evaluated by conducting chromatographic separations at seven
different gradient times (5, 10, 15, 20, 30, 40 and 50 minutes). Results in Figure 2.7 showed that
increasing the gradient time up to 30 minutes slightly improved the peak capacity but with no
significant increase with longer gradients. This observation confirms that the largest impact on
peak capacity occurs from the initial increases of gradient time. For example, changing the
gradient time from 5 to 10 minutes increased the peak capacity by 10% while increasing from 10
min to 30 minutes produced only a further 7% improvement.
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Both linear velocity and gradient time are shown to impact peak capacity and are easily
modified chromatographic parameters. With consideration to a reference point of separations
conducted at 1mL/min with a gradient time of 10 minutes (added references) our results
demonstrate that decreasing flow rate to 0.5 mL/min (Figure 2.6) (with a proportional increase in
the gradient time to 20 min) offers a greater increase in peak capacity compared to increasing the
gradient time alone (Figure 2.7). In addition, use of a lower flow rate is a more favorable
condition for MS analysis due to the expected increase in sensitivity.

Figure 2.7. The impact of gradient time on retention. Gradient times were 5, 10, 20, 30, 40 and
50 minutes and 42, 83, 167, 250, 333 and 417 column volumes respectively.
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2.4 Conclusion
In this study we evaluated the impact of elution parameters on the hybrid HIC separations
of mAbs and other large therapeutic biomolecules on a previously described stationary phase that
is more hydrophobic than typical used for HIC separations. This research demonstrated that an
adequate separation of mAbs and related molecules is achievable using a salt concentration (0.5
M) that was lower than what was previously reported as the lowest concentration required for
satisfactory chromatographic performance for a set of model proteins. Furthermore, the study
showed the analytical utility of low salt conditions to widen the chromatographic elution window
through the earlier elution of the hydrophilic analytes combined with the unexpected later elution
of the more hydrophobic analytes. Results from intrinsic fluorescence and MS of the eluted
biomolecules suggested that they were in a largely folded state despite the use of conditions that
employed a low salt mobile phase containing acetonitrile (referred as either MeCN or ACN)
which might be expected to cause denaturation especially in the presence of a hydrophobic
stationary phase. However, there are various orthogonal and conformational analysis techniques
that can provide more details to confirm the conformation changes under these chromatographic
conditions. In addition to widening the elution window, another advantage of the use of a lower
salt mobile phase was an approximate fivefold increase in the ESI-MS response of the analytes.
Since compatibly with on-line MS analysis is one of the main drivers for the development of
hybrid HIC, the increase in MS response represent a significant advance.

Other elution

parameters were also studied with the impact of linear velocity and gradient steepness generally
followed expected trends with the relatively modest loss of efficiency at the highest linear
velocity being noteworthy.
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Chapter 3 : Hybrid Mode of Hydrophobic Interaction
Chromatography of Monoclonal Antibodies and Related
Biomolecules: Influence of Mobile Phase pH, Organic Modifier and
Temperature on Poly (alkyl aspartamide) Silica Columns
3.1 Introduction
Factors affecting protein adsorption in HHIC systems include the properties of mobile phase
such as buffer pH, temperature, organic modifier and stationary phase in addition to salt type and
concentration. Out of all these factors, salt concentration and salt type

1-7

effects have received

the most attention. In HIC, Alberty et al. 8 derived a relationship to correlate how variations in
buffer pH, temperature and salt concentration can induce Gibbs energy changes. In his work he
concluded that the chromatographic affinity is driven by the change of Gibbs energy, which is
related to the number of water molecules released upon protein binding. Based on this number,
the effect of pH and temperature can be estimated. Xia et al. 9 found that when the buffer pH is
close to the isoelectric point of the protein, more water is released during adsorption. Baumann et
al.

10

conclude that pH-induced reversible structural changes and protein reorientation upon

binding can increase the dynamic binding capacity affecting retention process.
An organic modifier is required to elute biomolecules (Refer to Section 2.3) in a reasonable
time frame when using poly (alkyl aspartamide) silica columns with mass spectrometry
compatible salts such as ammonium acetate in low concentrations. Organic solvent helps to
disrupt hydrophobic interactions between the molecule and stationary phase to promote elution.
Organic solvent is known to denature biomolecule conformation and the details will be discussed
in Section 3.3.2. However, the impact of the organic solvent is highly dependent on the type and
the percentage of organic solvent and also on the properties of the biomolecule itself. Along with
mobile phase properties, column temperature also contributes to the elution. In conventional
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HIC the effect of temperature on solute binding columns has been previously examined and it
was found that retention is an entropically driven process at low temperature and an enthalpically
driven process at high temperature. However, temperature effect on poly (alkyl aspartamide)
silica columns has not been studied and is yet to be evaluated. Our research will help to
demonstrate the effect of mobile pH and, organic modifier and will also provide insights on the
impact of temperature on the separation.

3.2 Experimental Details
Details on the chemicals, HIC columns, mAbs, HPLC system and chromatographic
conditions, refer to Section 2.2. Acetonitrile, isopropyl alcohol and methanol was purchased
from Sigma Aldrich, 0.1N ammonium hydroxide was purchased from Ricca Chemicals, and
glacial acetic acid was purchased from Sigma Aldrich and were used to adjust the pH of aqueous
mobile phases before adding the organic solvent. Unless otherwise specified chromatographic
separations were performed at 25°C with initial 0.5 minutes hold and a 10 min linear gradient
going 100% mobile phase A to 100% mobile phase B. 1 M NH4OAc was used as mobile phase
A and 20mM NH4OAc (overall) with 50% MeCN as mobile phase B. Mobile phases were
prepared as pH range of 5.7 - 7.3. Isoelectric points (pI) of mAb 1 was 8.3, mAb2 was 7.2, mAb3
(NIST mAb) is 9.2, mAb4 is 9.5, mAb5 is 9.0 and FC protein is 7.7

3.3 Results and Discussion
In this research, mobile phase parameters such as pH, temperature, organic type and
content were studied to evaluate the retention and selectivity on a mixture of six biomolecules
using poly (alkyl aspartamide) silica columns. Poly PENTYL A column was selected for this
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research after a brief evaluation of available stationary phases such as PolyPROPYL A,
PolyBUTYL A, PolyHEXYL A and PolyHEPTYL A columns (Figure 3.1). This column was
found to be most suitable for the separation of selected biomolecules and also in agreement with
recent reports 7, 11.

Figure 3.1. Initial evaluation of chromatographic separation using different poly (alkyl
aspartamide) silica columns

3.3.1 Effect of mobile phase pH on the retention
HIC is strongly influenced by the pH of the solution, however, the effect of pH in HIC is not
completely understood 12-15. In most cases, it was observed that an increase in pH can reduce the
hydrophobic interactions between molecules and the hydrophobic groups of the stationary phase,
may be as a result of increased titration of charged groups, leading to the increased
hydrophilicity promoted by the change (increase) in the protein charge

5, 12

. Hjerten et al.

16

reported that basic protein such as lysozyme displayed high binding when the buffer pH was
close to its pI and human serum albumin capacity factor decreased as the pH increased. The net
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charge on the molecule is affected by pH of its surrounding environment and can become more
positively or negatively charged due to the gain or loss, respectively, of protons (H⁺). Therefore,
depending on the pH, the protein’s net charge and its conformation can change significantly 9-10,
16-18

. It is well established in the literature, that hydrophobic interactions are stronger when

solution pH is close to the isoelectric point of the protein

17

. The reason is, near its isoelectric

point the net charge of the protein will become zero and the electrostatic repulsion between the
protein molecules becomes small, favoring a closer packing on the adsorbent surface 17.
In general, the commonly used pH conditions for larger biomolecules are in the range of
physiological pH which is in between 6.4 and 7 6. However, most of the biomolecules stored in
the range pH 5.7 - 7.3, because they exhibit high chemical and physical stability. Keeping this in
mind, in this research, pH range was evaluated between 5.7 and 7.3, while all other
chromatographic parameters were kept constant (Figure 3.1). The results demonstrated that
peaks 1 and 2, where the pIs are close to 8, retained longer and exhibited low resolution at low
pH (5.7) and eluted faster with increased resolution as the pH increased to 7.3. In general, when
the pH is less than pI, a molecule contains positive charge. The increased protein retention at low
pH could be due to partial denaturation

19

or disruption in both ionic and hydrophobic

interactions. This scenario will result in stronger adsorption onto stationary phase. Based on
earlier research 18, it was explained that the ionization state of amino acids in the contact surface
area influences the strength of the hydrophobic interaction. Hence, not only hydrophobicity, but
hydrophilicity also affects HIC retention. In conclusion, there is a strong influence of the buffer
pH on the adsorption strength resulting from both configurational changes and electrostatic
effects

20

. As the pH increases and gets close to pI of the molecule, the net charge of the

molecule gets closer to 0, causing a decrease in electrostatic interactions. As a result, only
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hydrophobic interactions of the molecule play a role and it is easy for organic to disrupt these
interactions by causing earlier elution.
In this research, for peaks 1 and 2, as the pH increased from 5.7 to 7.3, there was a decrease
in peak retention and increase in peak resolution. The reason for this observation may be similar
to what was described

9

as the change in pH impacts the total number of released water

molecules upon protein binding. This number increases as the buffer pH approaches the
molecule’s pI and decreases when the pH was away from its pI. This influence impacts the
selectivity of the biomolecule on HIC systems 9. A very similar trend was observed for peak 3
(NIST mAb), where the pI is 9.2. A decrease in the retention time occurred when the pH
increased to pH 7.3. Peaks 4 and 5 have similar pI values as peak 3 but there was no major shift
in the retention observed. However, there is a slight decrease in the resolution between these two
peaks. There was an interesting observation made with peak 6, where the pI of the molecule is
similar to peak 2. The change in the retention was completely negligible. Hjertén et al. observed
that the retention of various test proteins changed more drastically at pH values above 8.5 and/or
below 5 than in the range pH 5 – 8.5

16

. The shift in retention caused by the pH is highly

dependent on the biomolecule. The pI and the number of charged amino acid residues in the
biomolecule have an impact 5. Therefore, although the pI of the mAbs is typically higher than
biological pH, the effect of buffer pH may vary depending on the molecule properties such as the
available amino acids in the contact surface area and the number of the water molecules released.
Although there has been an explanation for the impact of pH on the retention mechanism, it is
very complex to predict the retention process as there are multiple parameters simultaneously
changing during the gradient run. As described in previous findings and the outcome of this
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research, pH may not be a critical parameter 6 but it has an impact on selectivity (Figure 3.2) and
peak capacity (Figure 3.3). Hence, it can be used to optimize the separation of biomolecules.

Figure 3.2. Effect of mobile phase pH on retention and selectivity
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Table 3.1. Changes in the retention factor in different mobile phase pH

Mobile phase pH
Peaks

5.7

6.0

6.3

6.5

7.0

7.3

mAb1

20.7

18.0

16.0

15.2

14.0

13.3

mAb2

24.1

22.5

21.2

20.8

19.8

19.3

NIST

30.9

29.3

28.1

27.8

27.3

26.9

mAb4

36.3

36.2

36.1

36.4

36.8

36.3

mAb5

41.3

40.7

40.1

40.2

40.3

39.6

mAb6

47.4

46.8

46.4

46.8

47.2

46.5

Figure 3.3. Effect of mobile phase pH on the peak capacity
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3.3.2 Effect of organic modifier concentration on the retention
Adding a small portion of organic solvent will contribute to disruption of hydrophobic
interactions in HIC, resulting in elution of bound molecules. However, the impact of the organic
solvent depends on the properties of the organic solvent and the molecule as well. In general,
molecules with α-helix seems to be more stable compared to molecules with β-sheets. The reason
for this is that β-sheets have more solvent accessibility compared to α-helix, therefore, molecules
with β-sheets tend to denature faster 21. In the absence of water, proteins in hydrophobic solvents
were thought to retain their native structure as a result of kinetic trapping

22

, which is due to

stronger hydrogen bonding between the protein atoms and a more rigid structure. In hydrophobic
water-immiscible solvents, the available water will tend to stay at the protein surface as a result
of the solvophobic and hydrophilic nature of the protein surface 23. In 1999, Klibanov indicated
that a small amount of water (1% v/v) will have significant impact on increase of catalytic
activity because water plays an important role in the structure and dynamics of the protein 24. On
the other hand, polar solvents such as dimethyl sulfoxide [DMSO], dimethylformamide [DMF]
and, formamide can easily strip water from protein surface and compete strongly for hydrogen
bonds between protein atoms by denaturing to a significantly unfolded state of the molecule 25.
However, due to the presence of a hydrophilic component, alcohols moderately compete for
amide hydrogen bonds and will disrupt tertiary structure leaving secondary structure interactions
intact 26.
Methanol is a commonly used organic solvent for chromatographic separations. The
assumption is, due to its polar protic nature it works as a denaturant and increases the
concentration of possible folding intermediates

26

, hence, it may not be a good choice for the

separation. Previous experimental results and theoretical studies have shown that the addition of
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methanol to aqueous protein solutions stabilizes (or even induces) the α-helical structure.
However, it denatures other protein structures, caused by the accumulation of methanol near the
protein surfaces

27-29

. This behavior induces the expansion of protein structure (Figure 3.4)

possibly by the reduction of hydrophobic effects. Simultaneously, the replacement of water
molecules from the protein surface decreases the hydrogen bonding between water and the
protein and increases the protein-protein hydrogen bonds

30

. Although disruption of water shell

in the presence of methanol increases the exposure of the protein to solvent. Combination of
these effects locally decrease the polar interactions between the solvent and the protein causing
an increase in the possibilities for secondary structure formation

30

. However, the effect of

methanol on protein structure depends on the sequence and the position of the amino acids.
Therefore, it is a combination of interdependent direct (preferred binding of methanol) and
indirect (e.g., reduced protein-water hydrogen bonding) effects

30

. Based on the reference, the

influence of methanol depends on multiple factors such as the amino acid sequence, the
environment of the biomolecule and also the balance between the interactions. Combination of
all these effects will determine whether methanol tightens or loosens the protein structure

30

,

which may act as a protein denaturant. Various studies were conducted over a wide range of
water/organic solvent mixtures and it was observed that proteins in solvents containing different
proportions of water and organic solvent showed very different behavior than that observed in
either water alone or neat organic solvent 22.
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Figure 3.4. NMR structure of BBA5 in a) water, and b) MeOH/water solution. The side-chains of
hydrophobic residues participating in the hydrophobic cluster in water are indicated 30.
(Reprinted with the permission of ACS)

The effect of MeCN-water mixtures on the solubility of amino acids in lysozyme
indicated very similar observations as with other organic solvents. They tend to weaken the
hydrophobic interactions by enhancing the peptide-peptide hydrogen bonding leading to the
denaturation of proteins. Circular dichroism confirmed that the confirmation of lysozyme
remained native up to 40% of MeCN 31. 2016 Bobaly et al. 32 performed experiments to evaluate
the effect of MeCN using commercial HIC columns. MAbs with low or moderate hydrophobicity
demonstrated longer retention with lower percentage of MeCN and lower retention was observed
as the percentage of MeCN increased, whereas for most hydrophobic mAbs, the retention
decreased continuously as the concentration of MeCN increased. Longer retention indicated
some possible structural changes depending on the proportion of the MeCN, which impacts the
confirmation and contact area of the proteins with the stationary phase. Larger proteins exhibit
deviations from the linear solvent strength (LSS) retention mechanism in RPLC mode indicating
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potential conformational changes in the molecule

33-34

. In HIC mode the effect of organic

depends on the aprotic nature because some mAbs showed decreasing retention in previous
studies (at ambient temperature), when the amount of IPA (protic solvent) in the mobile phase
increased 6. Bobaly et al. 32 mentioned that protic solvent (IPA) can be better solvent than aprotic
solvent (ACN) to minimize the denaturation when used up to 10-15%. However, the effect of
organic will depend on the nature of the molecules. Small percentage of organic solvent may
have very minor effect on conformation changes but will have significant effects on folding
thermodynamics 35.
Organic modifier in the mobile phase plays a significant role in HIC in selectivity and
resolution. As per earlier research findings

3-4, 6-7, 11, 32, 36-37

small amount of organic in mobile

phase B is useful and will dramatically improve the separation without impacting the
conformation of the biomolecule. HIC separation using poly (alkyl aspartamide) silica columns
require some percentage of organic solvent to elute molecules using low concentration of
ammonium acetate 4. In earlier research it was mentioned

4-6, 32

that in HIC separation, alcohols

(specifically isopropanol) improved selectivity and it also been reported that in many cases
isopropanol was a less denaturing solvent than MeCN when temperature kept below 40°C 32.
In this research a sequence of experiments were conducted separately to evaluate the
impact of different percentages of methanol, isopropanol and MeCN to compare the selectivity
and separation. Of the molecules that were used in this research, MeCN provided better
separation and selectivity as compared to IPA and MeOH when ammonium acetate gradient was
used (manuscript). MeOH and isopropanol percentages were adjusted to match MeCN solvent
strength and the impact of MeOH was evaluated using 40%, 62.5% and 75% concentrations in
mobile phase B. There was no elution observed with 40% and partial elution was observed with
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62.5% and 75% MeOH (Figure 3.5). This may be due to the conformation changes and result in
interactions with the stationary phase. Similarly, 15% and 25% IPA (Figure 3.6) in mobile phase
did not provide an adequate separation. However, 40% IPA enables the separation of variants
which was not observed with MeCN. Use of IPA can be further evaluated to gain knowledge on
separating variants. This important observation can lead to new opportunities of quantifying
variants of a mAb.

Figure 3.5. The effect of methanol on the separation of six mAbs
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Figure 3.6. The effect of IPA on the separation of six mAbs
To study the workable range of MeCN, a series of experiments were carried out (Figure
3.7) by varying the concentration (25% to 75%) in mobile phase B while all other parameters
were kept constant. Results of mobile phase B with 25% MeCN showed that more hydrophilic
molecules retained longer compare to higher concentrations of MeCN and no elution was
observed for more hydrophobic molecules indicating that the MeCN concentration is not enough
to disrupt the hydrophobic interactions to promote elution. Mobile phase B with 35% MeCN
contributed to elute the peaks, but a wider elution window was observed. This condition can be
effectively utilized to increase the peak capacity. In mobile phase B with 50% MeCN, the
separation was not only adequate but also earlier elution was observed. As MeCN percentage
increased from 50% to 75% the trend continued with good selectivity (Figure 3.7) and increase
in peak capacity (Figure 3.8). In addition, peaks appeared sharper than mobile phase B with
50% MeCN demonstrating similar peak recovery. As there was neither co-elution nor peak
splitting observed, it was assumed that molecules retained their mostly folded state or native-like
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conformation even with 75% MeCN in mobile phase B. However, to confirm the conformational
changes more experiments are required. In these experiments, it was evident that peaks retained
longer with an increase in the salt concentration (higher mobile phase A percentage), which is an
expected conventional HIC retention behavior.

Figure 3.7. Effect of MeCN on the separation of six mAbs
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Figure 3.8. Increase in peak capacity with an increase in percentage MeCN in mobile phase B in
the presence of 1M salt in mobile phase A

3.3.3 Effect of column temperature on the retention
The temperature effect on HIC performance has been very well studied

9, 16, 38-41

. In

general, in HIC, the retention factor, k, increase with an increase in temperature

38, 42

and

lowering the temperature enhances the protein elution 38. It is well known that in the folded state
protein retention is less in HIC compare to an unfolded state 43. This is because in an unfolded
state, the increase in the retention is due to the increase of hydrophobic interactions as a result of
the temperature-induced conformational changes of biomolecules and/or related to the increase
in the hydrophobic contact area upon binding to the chromatographic surface

43-45

. Hence,

retention is nonlinear with temperature due to protein conformational changes, which leads to an
increase in the conformational entropy at higher temperature

42-43

. Wei et.al

42

proved that the

total moles of solvent released at the contact region between the stationary phase and the solute
93

interface when 1 mole of solvated solute is absorbed is not same for all the molecules. This
number highly depends on the conformational stability of the molecule. The conformational
change of proteins will contribute to the increase in hydrophobic contact area between the
molecule and the stationary phase. With that, it was confirmed that the increase in the solvent
depends on two factors, one is the changes in the number of water molecules surrounding the
molecule due to conformational changes of molecules, and the other is a result of an increase in
hydrophobic contact area between the protein and the stationary phase. On the other hand, it was
clear that the adsorption is accompanied by the release of a large number of water molecules.
This supports the expectation of an entropically driven process in which the release of a large
number of ordered water molecules provides the driving force for adsorption. This confirmation
supports Hjertén et. al findings 38.

At low temperatures large and positive enthalpy and entropy changes were observed. In the
literature 41, 46-48, HIC is an entropy-driven process and the Gibbs free energy is given according
to the Eq. (1).
∆G = ∆H - T∆S

(1)

Since ∆H may be a small positive or negative value, ∆G is controlled by a positive entropy
change and hence increases with an increase in temperature. According to El Rassi, in HIC the
retention factor k’ increases with increasing temperature according to the below equation 40:
ln k’ = ln φ - ∆G/RT

(2)

Where R is the gas constant, φ is the phase ratio and T is the absolute temperature. However,
based on the impact of temperature on the conformational state of different biomolecules and on
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their solubility in aqueous solutions, an opposite behavior can be observed in protein retention.
In HIC system, protein unfolding is affected by hydrophobic and static electronic force between
protein and stationary phase beside the force of the interior of the molecule as temperature
increased

42

. Enthalpy–entropy compensation relationship can be used to explain HIC retention

process 47, 49. Even though the effect of temperature in HIC is not straightforward, this parameter
can be used to promote elution by weakening the interactions and separating proteins under mild
conditions without denaturing the molecule 40.
To demonstrate the effect of temperature using poly(alkyl aspartamide) silica columns
and assess the retention in HHIC, an experimental study was designed by varying temperatures
in the range of 20°C and 30°C, with 25°C being a control for this research. The temperature
limitation for these columns is 35°C. The columns used in the study were PolyBUTYL A,
PolyPENTYL A, PolyHEXYL A and PolyHEPTYL A. No significant difference was observed
on the retention going from 20°C to 25°C using PolyPENTYL A columns, therefore 20°C was not
evaluated for PolyBUTYL A, PolyHEXYL A and PolyHEPTYL A columns. However, as the
temperature increased from 25°C to 30°C (Figure 3.9) unlike conventional HIC, an earlier elution
was observed for PolyPENTYL A column (Figure 3.10) and the same trend was observed in all
other columns. This is an atypical behavior compared to what was described for conventional
HIC methodology. The hypothesis for this behavior is that increase in temperature may be
effecting in the diffusion of the molecule through the stationary phase or in lower temperatures
hydrophobic effect becomes weaker, resulting in early elution

42, 50

. This experiment

demonstrated that overall there is no significant impact of separation of these mAbs at the range
of temperatures 20°C - 30°C (Figure 3.10).
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The aim of this research is to enhance the fundamental knowledge about the retention
behavior of hybrid HIC using poly (alkyl aspartamide) silica columns by studying
chromatographic parameters such as concentration of salt, pH, and organic solvent and
demonstrate the effect of temperature with no intention of evaluating thermodynamic model. The
results generated in this research based on chromatographic parameters, such as concentration of
salt, pH, and organic solvent are not suitable to assess thermodynamic properties such as entropy
and enthalpy. Therefore, a thermodynamic model was out of the scope of this research.

Figure 3.9. Effect of temperature on PolyPENTYL A column
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Figure 3.10. Changes in the retention factor with the column temperature using PolyPENTYL A
column.

3.3.4 Effect of Salt in Mobile Phase B (20mM ammonium acetate with 50%
MeCN)
Salt concentration in mobile phase A plays a significant role in molecule retention on HIC
methodology. In this research the separation was based on a decreasing salt gradient with
20mM salt in mobile phase B which is a very low concentration. With a closer look it is obvious
that all six peaks eluted before 5 minutes in the presence of half the amount of mobile phase A
where the concentration is about 500 mM. The assumption is, in the presence of high salt (500
mM) in mobile phase A and low salt (~10 mM) in mobile phase B, there may not be a great
impact on the elution and separation. To study the importance and measure the role of salt
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concentration on mobile phase B, we performed experiments (Figure. 3.11) using mobile phase
A with 1 M and mobile phase B with pure water and 50% MeCN in water (no salt).
The results confirmed that as described in section (2.3) organic solvent is required for the
elution of the peaks using PolyPENTYL A column when used with low concentrations of
ammonium acetate as mobile phase A. It was evident that the separation was very similar (Table.
3.2) with and without 20 mM salt present in mobile phase B. Therefore, it was clear that the low
salt that achieved through the gradient steepness may be low enough to rebuild the hydration
shell around the biomolecule and organic solvent will help to break hydrophobic interactions by
promoting the elution. This experiment confirmed that an adequate chromatographic separation
can be achieved using 1M ammonium acetate as mobile phase A and mobile phase B with or
without 20mM ammonium acetate (overall) with 50% MeCN using PolyPENTYL A column.

Figure 3.11. PolyPENTYL A column with 1000 Å and 3 um: Evaluation of chromatographic
separation (MP A: 1 M NH4OAc at pH 7.0 and MP B: water, water with 50% MeCN and 20 mM
with 50% MeCN @ an aqueous pH 7.0)
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Table 3.2. Comparison of mobile phase B using PolyPENTYL A column with 1000 Å and 3 um
particle size: 1 M ammonium acetate as mobile phase A and 50% of MeCN with and without 20
mM ammonium acetate as mobile phase B
Mobile phase
composition

1M_20mM50%MeCN

1M_water50%MeCN

Peak
name

Tailing
Factor

Resolution

Retention
Factor

Selectivity

mAb1

1.05

NA

16.1

NA

mAb2

1.17

3.93

28.1

1.75

NIST

1.17

2.37

34.2

1.22

mAb4

1.24

3.08

40.6

1.19

mAb5

1.11

1.96

44.1

1.09

mAb6

1.12

5.99

54.9

1.25

mAb1

1.05

NA

15.9

NA

mAb2

1.15

3.94

27.9

1.76

NIST

1.19

2.31

33.9

1.22

mAb4

1.23

3.06

40.2

1.19

mAb5

1.14

1.91

43.6

1.09

mAb6

1.10

5.88

54.6

1.25
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Peak
Capacity

76

71

3.4 Conclusion
The purpose of this study was to demonstrate the influence of chromatographic parameters
that impact selectivity and retention. Parameters such as mobile phase pH, organic type and
percentage and temperature are shown to effect chromatographic performance. The research
finding suggests that mobile phase pH variation in the range of 5.7 - 7.3 may not be a critical
parameter to improve the separation for some mAbs, but for other mAbs the impact is
significant. The reason for this behavior is, the changes in the pH will change the charge on the
molecule due to the ionization of acidic groups. Hence, it is worth to evaluate mobile pH to tune
the selectivity using poly (alkyl aspartamide) silica columns.
It was demonstrated that an organic solvent has a significant impact on the elution using
HHIC technique due to the use of longer alkyl chains in stationary phase in the presence of low
concentrations of NH4OAc. In this research, different organic solvents and their percentages in
mobile phase B showed a significant difference in selectivity. The data proved that MeOH
cannot provide adequate elution for the selected mixture of biomolecules and to provide
adequate separation, at least 35% MeCN is required for acceptable separation. 40% IPA
demonstrated complex chromatogram with multiple peaks for each component, which appears it
has the capabilities to separate variants. This observation can be further evaluated. It was well
established that in conventional HIC along with mobile phase parameters, temperature plays a
major role. Unlike conventional HIC, in HHIC with poly (alkyl aspartamide) silica columns
increasing temperature from 25°C to 30°C showed an early elution which is an atypical HIC
behavior. Based on this observation, temperature may not be a critical parameter but may
contribute to increase the peak capacity.
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The experiment to assess the importance of salt in mobile phase B confirmed that using pure
water as mobile phase B was unable to elute biomolecules from the column. However, small
percentage of MeCN in mobile phase B with or without 20 mM ammonium acetate provided
adequate separation with little or no distinguishable differences. The results confirmed that salt
in mobile phase B does not play a major role in biomolecule separation.
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Chapter 4 : Hybrid Mode of Hydrophobic Interaction
Chromatography of Monoclonal Antibodies and Related
Biomolecules: Impact of Stationary Phase and Its Interplay with
Mobile Phase Parameters
4.1 Introduction
Protein conformation plays a significant role on chromatographic behavior in protein
chromatography 1. Structural changes in the secondary, tertiary or quaternary structure can have
a major impact on retention, peak width and peak shape

1-2

. In addition to mobile phase

conditions, stationary phase ligands play a significant role and result in structural modifications
which can lead to changes in the retention behavior. Strong protein-surface interactions can force
partial exposure of the molecule hydrophobic interior 3. The reorientation of the molecule is
required to achieve optimal interaction between the hydrophobic groups and the alkyl chains on
stationary phase to adsorb on the chromatographic surface. These interactions will determine the
nature of adsorption-induced structural changes 3. Protein adsorption at stationary phase surface
is driven by the various interactions which exist between the protein and the groups that are
attached to the stationary surface. The interactions that play a role in protein adsorption are
hydrophobic interactions, electrostatic interactions, van der Waals interactions, hydrogen
bonding, coordination bonding, and conformational entropy
acquired from the literature Yu et al.

7

4-6

. Based on the knowledge

illustrated protein behavior in a diagram (Figure. 4.1).

Yano and Rabe et al. 6, 8 mentioned that when molecules exists as an individual entity and as an
ensemble, the protein adsorption phenomena at solid surfaces is mainly driven by their attraction
towards solid surfaces.
The amino acids nature and diversity such as hydrophobicity/hydrophilicity or
charged/neutral properties, leads to structural and functional complexity of the molecule. A
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protein consists of both positive and negatively charged groups and exists in a secondary or
tertiary structure. Protein folding patterns lead to a heterogeneous surface exhibiting specific
properties such as hydrophobic/hydrophilic as demonstrated in Figure 4.2. Protein behavior at
chromatographic surface becomes extremely complex due to this diversified surface properties
and as a result, adsorption often results in an interplay of attraction and repulsion interactions.
These interactions will drive to the protein preferred binding orientation, which can further effect
mass transport and protein conformational transitions such as unfolding and refolding. Unfolding
commonly occurs at the surface of the molecule due to complicated molecular interactions with
surfaces, especially for unstable proteins. Hence, separation of unstable biomolecules may
require more attention. Literature suggests either avoid using HIC technique

9-12

or to carefully

select mobile phase solvents and its composition. Other alternative is to add protein stabilizers
13-15

as additives 16-18 in the mobile phase before performing the analysis 7. Not only stationary

phase surface properties but protein properties, and operating parameters such as mobile phase
conditions, can drive all of these effects as well 7.
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Figure 4.1. Protein behavior on chromatographic surface 7
(Adopted with permission from Elsevier)

Figure 4.2. Biomolecule with heterogeneous surface composed of hydrophobic/hydrophilic
patches. The re-orientation and favored binding orientation of the molecule at hydrophobic
surface 7 (Adopted with permission from Elsevier)
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Figure 4.3. Biomolecule representing hydrophobic (Red) and hydrophilic (blue) areas 19
(Adopted with permission from creativecommons.org)
HIC stationary phases typically consist silica or a polymer bonded with alkyl or aryl
groups that have relatively limited hydrophobicity, for example butyl, phenyl, ether, amide, and
propyl (Figure 4.4). Straight chain alkyl groups exhibit hydrophobic character, whereas aryl
groups show mixed-mode behavior where both aromatic and hydrophobic interactions can play a
role in the adsorption process. Commercially available HIC stationary phases are non-porous and
made with either silica (MAbPac HIC-Butyl) or polystyrenedivinylbenzene (Proteomix HIC
Butyl) as a base material; however, there are also some porous and nonporous polymethacrylatebased (TSKgel Butyl-NPR) particles available. These columns will offer separation using nonvolatile salts such as phosphates and sulfates, which are incompatible with online MS. Therefore,
to extend MS compatibility Andrew Alpert synthesized new stationary phases (Section 1.8)
which can provide the separation using volatile salts such as acetate and tartrate.
Stationary phase properties such as base matrix, hydrophobicity, particle size and pore
size have a major impact on the selectivity. Base matrix plays a significant role in the separation
due to non-specific interactions such as electrostatic interactions, which can contribute to the
selectivity. Even though there is one alkyl group difference from propyl to butyl to pentyl,
propyl has access only when high salt has disrupted the hydration layer around the molecule.
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However, longer alkyl chains such butyl and pentyl can reach the hydrophobic patches even
when the water molecules are intact with the biomolecule, showing an adequate selectivity. It is
a well-established fact that smaller particles provide higher surface area, shorter diffusion paths
and increased mass transfer kinetics which will contribute to the reduction in plate height and
increase the efficiency. Similarly, the results from the columns with higher pore size demonstrate
shorter retention times, higher resolution and better efficiency. Even though larger pore size
provides low surface area, molecules can freely enter into these larger pores and can able to
interact with the stationary phase alkyl chains. In addition to column properties, mobile phase
properties such as buffer conditions can modify the apparent size of the biomolecule effecting
the resolution. As a whole, not only stationary phase properties by itself have a profound impact
on the selectivity but the interplay of both mobile phase and stationary phase can highly
influence the separation of biomolecules. In general, for biomolecules, large pore size with
shorter alkyl chain lengths provide better resolution.
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Figure 4.4. Increase in the hydrophobicity of HIC stationary phases.

HIC stationary phases are less hydrophobic compared to RPLC phases as the functional
groups are sparsely distributed, resulting in mild interactions

20

. Retention in HIC technique is

very sensitive and highly dependent on the alkyl type, alkyl chain length and alkyl density along
with mobile phase parameters demonstrated that salt type can have different effects on retention
depending on the hydrophobicity of the protein to be separated and the hydrophobicity of the
stationary phase itself. They also emphasized the importance of a well selected stationary phase
and the salt (phase system) 20-21 on the retention and selectivity. In addition, it was demonstrated
that the hydrophobicity of the stationary phase plays a significant role in maintaining native state
conditions upon elution from the chromatographic column 1.
HIC stationary phases made with poly (alkyl aspartimide) are more hydrophobic than
typical HIC stationary phases. The impact of mobile phase parameters on these columns play a
very similar role to conventional HIC columns. Due to their more hydrophobic nature and highly
retentive behavior the non-typical HIC columns can provide adequate retention using low
111

concentrations of MS compatible salts.

There are several stationary phases available with

different alkyl lengths such as propyl, butyl, pentyl hexyl, heptyl etc. with different pore size
such as 1000 Å and 1500 Å and particle sizes of 2 µm, 3 µm, 5 µm and 12 µm. The selection of
phase system and chromatographic conditions for therapeutic biomolecules are mostly subjective
and chosen based on the trial-and-error approach

22

. The separation and selectivity is highly

dependent on the stationary phase and mobile phase parameters and as well as, the interplay of
both parameters. As multiple parameters act simultaneously, the chromatographic behavior is
considered to be complex due to the interdependency of multiple gradients such as dynamic
changes in pH, salt and organic solvent. To demonstrate the capabilities and differences of these
stationary phases, we studied the selectivity of different columns with different pore sizes and
different particle sizes using the biomolecules which are used in this research.

4.2 Experimental Details
Details on the chemicals, HIC columns, mAbs, HPLC system and chromatographic
conditions, refer to Section 2.2. Unless otherwise specified chromatographic separations were
performed at 25°C with initial 0.5 minutes hold and a 10 min linear gradient going 100% mobile
phase A to 100% mobile phase B. 1 M NH4OAc was used as mobile phase A and 20mM
NH4OAc with 50% MeCN as mobile phase B. pH of all the mobile phases were measured for
aqueous solutions. Experiments were performed using columns with different column parameters
and also using mobile phases with different salt and organic concentrations. Please refer to the
details in Tables 4.1 and 4.2.
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Table 4.1. PolyBUTYL A and PolyPENTYL A column dimensions used in this research.

Columns (50 x 2.1 mm)

1000 Å

1500 Å

PolyPENTYL A

3 µm

2 µm

3 µm

2 µm

PolyBUTYL A

3 µm

-

-

-

Table 4.2. List of mobile phase A and mobile phase B compositions.
Mobile phase A
@ pH 7.0

Mobile phase B: % of MeCN in 20mM ammonium acetate @ pH 7.0

1M

25%

35%

50%

65%

75%

0.5 M

X

X

X

X

X

0.35 M

X

X

X

X

X

0.25 M

X

X

X

X

X
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4.3 Evaluation and Comparison of Retention in Different Poly (alkyl
aspartamide) Stationary Phases
The properties of these stationary phases result in different retention and selectivity. The
effect of salt and organic concentration on the chromatographic separation of the molecules can
vary considerably on different stationary phases with same hydrophobicity but different pore size
and particle size. The selected biomolecules were screened using PolyPROPYL A, PolyBUTYL
A, PolyPENTYL A, PolyHEXYL A and PolyHEPTYL A columns that were evaluated by Chen
et al.
23

23-25

and the initial conditions for the separation were adopted from their research findings

. After an initial evaluation (Figure 4.1) PolyBUTYL A and PolyPENTYL A columns

demonstrated very similar selectivity with an adequate separation. PolyHEXYL A column
showed poor recovery of early eluters and co-elution of late eluters. PolyHEPTYL A column
demonstrated similar chromatographic performance as PolyHEXYL A for late eluters but
showed no elution for early eluters. This observation of both stronger retention and co-elution of
the peaks may be due to the more hydrophobic nature of the longer alkyl chains stationary
phases. Compare to PolyBUTYL A, PolyPENTYL A column has more surface area leading to
higher efficiency. Therefore, it is found to be most suitable based on the tailing factor, resolution,
efficiency, peak capacity (Table 4.3) for the selected molecules which is in agreement with
previous report 23, 26.
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Figure 4.5. Comparison of the selectivity using different poly (alkyl aspartamide) columns (MP
A: 1 M NH4OAc and MP B: 20 mM NH4OAc with 50% MeCN @ pH 7.0)
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Table 4.3. Comparison of PolyBUTYL A and PolyPENTYL A columns chromatographic
performance.

PolyPENTYL A

PolyBUTYL A

Column Type

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

10.7

NA

mAb2

1.52

13.5

1.25

NIST

1.68

16.4

1.22

mAb4

3.26

20.9

1.27

mAb5

1.77

23.0

1.10

mAb6

2.52

26.1

1.13

mAb1

NA

12.6

NA

mAb2

1.61

14.7

1.17

NIST

2.01

16.8

1.14

mAb4

4.03

20.0

1.19

mAb5

4.17

22.9

1.15

mAb6

2.62

24.7

1.08

Peak Capacity

62
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Note: Poor recovery was observed using PolyPROPYL A, PolyHEXYL A and PolyHEPTYL A columns. Hence, data
was not included. Peak capacity was calculated using peak width@50% height.
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In sight of initial evaluation, both PolyBUTYL A and PolyPENTYL A columns were
chosen to extend the research to study the effect of different particle sizes and pore sizes on
chromatographic separation. The main purpose of the study was to evaluate the separation using
different phase systems (stationary phase and salt) in combination with different concentrations
of MeCN in mobile phase B. This study was performed to check if a lower salt concentration
(>0.5 M) can provide an adequate separation using columns packed with different pore sizes and
particle sizes for the mixture of biomolecules that are used in this research. To evaluate the
separation capabilities, an experiment was designed to use PolyPENTYL A columns with both
1000 Å and 1500 Å pore sizes with 3 um and 2 um particle sizes and PolyBUTYL A column
with 1000 Å pore size with 3 µm particle size. Different concentrations of ammonium acetate as
mobile phase A and 20 mM ammonium acetate with different percentages of MeCN as mobile
phase B was used to perform sample analysis. All these experiments were conducted using 1
mL/min flow rate at a column temperature 25°C unless otherwise specified.

4.3.1 PolyPENTYL A column with 1000 Å pore size with 3 µm particle size
PolyPENTYL A column with 1000 Å with 3 µm particle size was used for all previous
research experiments, hence, this column was considered as a control (Figure 4.6) for this study.
Peaks 1 through 6 are biomolecules used as a sample mixture. The difference in selectivity was
observed with 1M ammonium acetate as mobile phase A and 20mM ammonium acetate with
different concentrations of MeCN as mobile phase B (Table 4.4). Refer to Section 3.3 for the
details of the retention hypothesis. 25% MeCN was not strong enough to break the hydrophobic
interactions between the molecule and the stationary phase alkyl chains. The increase in MeCN
concentration showed good selectivity and a decrease in the resolution. Peaks appeared sharper
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showing a decrease in the retention time with a similar recovery. There was at least a two fold
increase in the peak capacity observed (Figure 4.7).
A significant difference in the selectivity (Figure 4.8) was observed with 0.5 M
ammonium acetate as mobile phase A and mobile phase B changing from 25% MeCN to 75%
MeCN. 25% and 35% MeCN was not enough to elute all the peaks and co-elution was observed
with 75% MeCN with a decrease in the resolution. Mobile phase A containing 0.5 M with 50%
and 65% MeCN with 20mM ammonium acetate gave adequate separation and the impact of the
salt concentration on the selectivity was explained in section 2.3. An important observation was
made that the chromatogram obtained in this study showed wider elution window compared to
the one obtained for Figure 2.2 using similar PolyPENTYL A columns. The reason may be due
to column to column variability, please refer to Section 4.10 for more details.
Mobile phase A with 0.35 M (Figure 4.9) and 0.25 M (Figure 4.11) in combination with
25%, 50%, 65% and 75% MeCN in mobile phase B resulted in co-elution or no elution of peaks.
To confirm the peaks order of the elution, individual molecules were injected using mobile phase
A with 0.35 M and 75% MeCN in mobile phase B and found that mAb4 and 6 retained on the
column showing no elution Figure 4.11. To enhance the elution of molecules in the mixture with
0.25 M, temperature was increased from 25°C to 30°C and coeluted peaks showed some
separation but not a significant difference from what was observed with 25°C. In summary,
PolyPENTYL A 1000 Å with 3 µm column give good separation with 1M and 0.5 M as mobile
phase A and 20 mM ammonium acetate with 50% and 65% MeCN as mobile phase B but lower
salt concentrations did not promote elution of the molecules. Peak capacity was calculated only
for the conditions where chromatographic separation was achieved.
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Figure 4.6. PolyPENTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 1M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Table 4.4. Comparison of chromatograms with 1 M ammonium acetate as mobile phase A and
different percentages of MeCN with 20 mM ammonium acetate as Mobile phase B using
PolyPENTYL A column with 3 µm, 1000 Å pore size.
Mobile phase
composition

1M and 20mM
with 35%MeCN

1M and 20mM
with50%MeCN

1M and 20mM
with 65%MeCN

1M and 20mM
with 75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

24.0

1.56

mAb2

4.31

37.2

1.56

NIST

2.04

42.9

1.16

mAb4

3.38

50.8

1.19

mAb5

2.13

55.4

1.09

mAb6

5.65

71.3

1.29

mAb1

NA

20.9

NA

mAb2

4.14

29.8

1.43

NIST

1.99

33.6

1.13

mAb4

2.66

37.9

1.13

mAb5

2.74

42.0

1.11

mAb6

4.47

48.6

1.16

mAb1

NA

19.5

NA

mAb2

3.98

26.8

1.38

NIST

1.90

29.9

1.12

mAb4

2.35

33.1

1.11

mAb5

2.82

36.7

1.11

mAb6

3.94

41.6

1.13

mAb1

NA

17.8

NA

mAb2

3.79

23.8

1.38

NIST

1.80

26.2

1.12

mAb4

2.06

28.5

1.11

mAb5

2.79

31.6

1.11

mAb6

3.47

35.3

1.13
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Retention Factor

59

91

106

127

Figure 4.7. PolyPENTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the peak capacity (MP A: 1M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).

Figure 4.8. PolyPENTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.5 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Table 4.5. Comparison of chromatograms with 0.5 M ammonium acetate as mobile phase A and
different percentages of MeCN with 20 mM ammonium acetate as Mobile phase B using
PolyPENTYL A column with 1000 Å and 3 µm column.
Mobile phase
composition

0.5M and
20mM with
50%MeCN

0.5M and
20mM with
65%MeCN

0.5M and
20mM with
75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

11.0

NA

mAb2

7.93

37.6

3.47

NIST

1.60

41.4

1.10

mAb4

1.73

45.3

1.09

mAb5

2.39

50.1

1.11

mAb6

4.82

71.5

1.43

mAb1

NA

10.2

NA

mAb2

6.50

32.4

3.23

NIST

1.39

35.0

1.08

mAb4

2.14

38.7

1.11

mAb5

1.57

41.2

1.06

mAb6

5.71

53.7

1.30

mAb1

NA

10.1

NA

mAb2

5.89

28.3

2.85

NIST

1.05

30.1

1.06

mAb4

2.07

33.4

1.11

mAb5

0.93

34.7

1.04

mAb6

5.52

43.8

1.26
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Retention Factor

48

66

77

Figure 4.9. PolyPENTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.35 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).

Figure 4.10. PolyPENTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity of individual mAbs (MP A: 0.35 M NH4OAc at pH 7.0 and MP B:
20 mM NH4OAc with 75% of MeCN with an aqueous pH 7.0).
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Figure 4.11. PolyPENTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.25 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).

4.3.2 PolyPENTYL A column with 1000 Å pore size with 2 µm particle size
PolyPENTYL A column with 1000 Å with 2 µm particle size in combination of 1M
ammonium acetate as mobile phase A and 20mM ammonium acetate with different
concentrations of MeCN as mobile phase B (Figure 4.12) demonstrated very similar selectivity
to PolyPENTYL A column with 1000 Å with 3 µm particle size column. 1 M with 25% MeCN
did not elute all the peaks but as the organic concentration increased to 35% and above, all six
molecules eluted with improved resolution. Mobile phase A with lower salt concentrations such
as 0.5 M, 0.35 M and 0.25 M (Figures 4.14, 4.15 and 4.16) with different percentages of MeCN
as mobile phase B, either did not elute or co-eluted peaks showed lack of selectivity under these
conditions. This experiment confirmed that PolyPENTYL A column with 1000 Å with 2 µm
particle size can be used with only 1 M with 35%, 50%, 65% and 75% MeCN in 20 mM
ammonium acetate. Peak capacity was calculated only for the conditions where chromatographic
separation was achieved.
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Figure 4.12. PolyPENTYL A column with 1000 Å and 2 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 1 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Table 4.6. Comparison of chromatograms with 1 M ammonium acetate as mobile phase A and
different percentages of MeCN with 20 mM ammonium acetate as Mobile phase B using
PolyPENTYL A column with 1000 Å and 2 µm column.
Mobile phase
composition

1M and 20mM
with 35%MeCN

1M and 20mM
with50%MeCN

1M and 20mM
with 65%MeCN

1M and 20mM
with 75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

12.9

NA

mAb2

5.21

20.5

1.58

NIST

2.98

24.1

1.17

mAb4

4.96

28.8

1.20

mAb5

3.41

31.7

1.10

mAb6

9.03

40.4

1.27

mAb1

NA

11.3

NA

mAb2

4.82

16.4

1.44

NIST

2.77

18.7

1.14

mAb4

3.81

21.2

1.13

mAb5

4.13

23.6

1.11

mAb6

6.5

27.3

1.16

mAb1

NA

11.1

NA

mAb2

4.72

15.1

1.35

NIST

2.69

16.8

1.11

mAb4

3.33

18.5

1.10

mAb5

4.94

20.9

1.12

mAb6

5.22

23.3

1.11

mAb1

NA

10.1

NA

mAb2

4.57

13.2

1.30

NIST

2.45

14.5

1.10

mAb4

2.83

15.7

1.08

mAb5

4.72

17.7

1.12

mAb6

4.36

19.4

1.10
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Retention Factor

82

121

154

184

Figure 4.13. PolyPENTYL A column with 1000 Å and 2 µm particle size: Impact of MeCN
percentage on peak capacity (MP A: 1 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).

Figure 4.14. PolyPENTYL A column with 1000 Å and 2 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.5 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0)
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Figure 4.15. PolyPENTYL A column with 1000 Å and 2 µm particle size: Impact of MeCN
percentage on the selectivity using (MP A: 0.35 M NH4OAc at pH 7.0 and MP B: 20 mM
NH4OAc with different percentages of MeCN with an aqueous pH 7.0).

Figure 4.16. PolyPENTYL A column with 1000 Å and 2 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.25 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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4.3.3 PolyPENTYL A column with 1500 Å pore size with 3 µm particle size
The selectivity of PolyPENTYL A column with 1500 Å with 3 µm particle size was not
adequate in 1 M with 25% MeCN in 20 mM ammonium acetate, however, as the organic
concentration increased to 35% and above, resolution of the peaks increased (Figure 4.17) as did
peak capacity (Figure 4.18). 0.5 M salt concentration did not provide acceptable separation
(Figure 4.19) with an increase of MeCN that was used in this research. However, 0.35 M as
mobile phase A with 50%, 65% and 75% MeCN as mobile phase B showed early elution of peak
1 but provided good chromatographic performance demonstrating these conditions can be used
for chromatographic separation (Figure 4.20). Resolution decreased as the organic content in
mobile phase B increased due to improved peak capacity (Figure 4.21). Surprisingly, 0.25 M in
combination with 65% and 75% MeCN displayed adequate elution (Figure 4.22) proving that
this column can be one of the choices to achieve chromatographic separation at low salt
concentrations. Peak capacity was calculated only for the conditions where chromatographic
separation was achieved.
In this study it appeared that there was a change in the selectivity of mAbs at
comparatively low starting salt concentrations such as 0.35 M and 0.25 M. The hypothesis for
this finding was that the concentration of salt plays a significant role in disrupting hydration shell
around the biomolecule and it is highly dependent on the properties of the biomolecule. The
thickness of the hydration shell can contribute to the changes in the strength of hydrophobic
interactions between the molecule and the stationary phase due to the exposure of more
hydrophobic patches resulting in an increase in the adsorption for some mAbs. Pore size is a
well-established column parameter and increase in pore size decreases the surface area. The pore
size of these columns are large enough to accommodate biomolecule diffusion and the results
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from the experiments do not provide details to predict the impact of the pore size on the
chromatographic separation. The influence and the interdependency of low salt concentration on
increased pore size is not completely understood and yet to be determined.

Figure 4.17. PolyPENTYL A column with 1500 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 1 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Table 4.7. Comparison of chromatograms with 1 M ammonium acetate as mobile phase A and
different percentages of MeCN with 20 mM ammonium acetate as Mobile phase B using
PolyPENTYL A column with 3 µm, 1500 Å pore size.
Mobile phase
composition

1M and 20mM
with 35%MeCN

1M and 20mM
with50%MeCN

1M and 20mM
with 65%MeCN

1M and 20mM
with 75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

12.9

NA

mAb2

4.48

18.8

1.44

NIST

4.66

24.1

1.28

mAb4

5.24

28.9

1.20

mAb5

3.47

31.8

1.10

mAb6

9.17

40.1

1.26

mAb1

NA

11.3

NA

mAb2

4.25

15.3

1.35

NIST

4.24

18.7

1.22

mAb4

4.05

21.3

1.14

mAb5

3.97

23.7

1.11

mAb6

7.13

27.8

1.17

mAb1

NA

10.6

NA

mAb2

4.17

13.8

1.29

NIST

4.12

16.5

1.19

mAb4

3.57

18.4

1.11

mAb5

4.40

20.6

1.12

mAb6

6.15

23.6

1.14

mAb1

NA

9.78

NA

mAb2

3.88

12.3

1.26

NIST

3.70

14.4

1.17

mAb4

3.03

15.8

1.10

mAb5

4.18

17.6

1.11

mAb6

5.31

19.8

1.13
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Retention Factor

94

134

164

189

Figure 4.18. PolyPENTYL A column with 1500 Å and 3 µm particle size: Impact of MeCN
percentage on peak capacity (MP A: 1 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).

Figure 4.19. PolyPENTYL A column with 1500 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.5 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Figure 4.20. PolyPENTYL A column with 1500 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.35 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0.

133

Table 4.8. Comparison of chromatograms with 0.35 M ammonium acetate as mobile phase A
and different percentages of MeCN with 20 mM ammonium acetate as Mobile phase B using
PolyPENTYL A column with 3 µm , 1500 Å pore size.
Mobile phase
composition

0.35M and
20mM with
50%MeCN

0.35M and
20mM with
65%MeCN

0.35M and
20mM with
75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

4.81

NA

mAb2

8.68

18.9

3.74

NIST

1.68

20.3

1.07

mAb4

2.99

22.6

1.11

mAb5

4.5

25.8

1.14

mAb6

7.05

33.1

1.28

mAb1

NA

4.81

NA

mAb2

4.25

16.5

3.28

NIST

4.24

17.4

1.06

mAb4

4.05

19.5

1.12

mAb5

3.97

21.4

1.10

mAb6

7.13

26.7

1.24

mAb1

NA

4.81

NA

mAb2

7.00

14.0

2.79

NIST

0.97

14.6

1.04

mAb4

3.09

16.3

1.11

mAb5

2.53

17.4

1.07

mAb6

7.57

21.3

1.21
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Retention Factor

75

91

108

Figure 4.21. PolyPENTYL A column with 1500 Å and 3 µm particle size: Impact of MeCN
percentage on peak capacity (MP A: 0.35 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).

Figure 4.22. PolyPENTYL A column with 1500 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.25 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Table 4.9. Comparison of chromatograms with 0.25 M ammonium acetate as mobile phase A
and 65% and 75% of MeCN with 20 mM ammonium acetate as Mobile phase B using
PolyPENTYL A column with 3 µm, 1500 Å pore size.
Mobile phase
composition

0.25M and
20mM with
65%MeCN

0.25M and
20mM with
75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

2.91

NA

mAb2

12.06

20.1

6.35

NIST

2.82

22.3

1.11

mAb4

2.38

24.3

1.09

mAb5

4.71

29.4

1.21

mAb6

3.86

37.9

1.29

mAb1

NA

2.80

NA

mAb2

10.51

16.7

5.43

NIST

2.95

18.5

1.11

mAb4

1.59

19.5

1.05

mAb5

4.23

22.4

1.15

mAb6

5.25

27.1

1.20
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Retention Factor

60

95

4.3.4 PolyPENTYL A column with 1500 Å pore size with 2 µm particle size
PolyPENTYL A column with 1500 Å with 2 µm demonstrated adequate selectivity using 1M
ammonium acetate as mobile phase A in combination with all five concentrations of MeCN in
20mM ammonium acetate as mobile phase B that were evaluated in this study (Figure 4.23).
Every mobile phase condition demonstrated sharper peaks, high resolution, and selectivity with
high peak capacity (Figure 4.24) compared to other columns that were evaluated in this study.
Separation in 0.5 M with different percentages MeCN resulted in co-elution of peaks as the
organic concentration increased from 25% to 75% (Figure 4.25). 0.35 M as mobile phase A with
50% MeCN and higher concentration of organic in mobile phase B showed very good selectivity
demonstrating an option to achieve adequate separation under low salt conditions (Figure 4.26)
with an enhanced peak capacity (Figure 4.27). An interesting observation was made in the
presence of mobile phase A containing 0.25 M with mobile phase B with 75% MeCN. This
condition demonstrated the separation of variants for mAb1 and mAb2. If conditions are
optimized, this combination can be exploited to separate minor variants of a mAb (Figure 4.28).
Peak capacity was calculated only for the conditions where chromatographic separation was
achieved.
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Figure 4.23. PolyPENTYL A column with 1500 Å and 2 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 1 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Table 4.10. Comparison of chromatograms with 1 M ammonium acetate as mobile phase A and
65% and 75% of MeCN with 20 mM ammonium acetate as Mobile phase B using PolyPENTYL A
column with 2 µm, 1500 Å pore size.
Mobile phase
composition

1M and 20mM
with 25%MeCN

1M and 20mM
with35%MeCN

1M and 20mM
with 50%MeCN

1M and 20mM
with 65%MeCN

1M and 20mM
with 75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

11.8

NA

mAb2

5.37

17.6

1.48

NIST

5.14

22.2

1.26

mAb4

5.41

24.0

1.20

mAb5

8.30

32.9

1.23

mAb6

7.97

36.9

1.12

mAb1

NA

11.5

NA

mAb2

5.36

16.8

1.45

NIST

5.07

20.9

1.25

mAb4

5.41

24.4

1.17

mAb5

6.64

28.6

1.17

mAb6

9.43

34.9

1.22

mAb1

NA

10.9

NA

mAb2

5.32

15.3

1.40

NIST

4.80

18.6

1.22

mAb4

4.67

21.1

1.14

mAb5

6.75

24.4

1.15

mAb6

6.69

27.5

1.13

mAb1

NA

10.2

NA

mAb2

5.34

13.9

1.37

NIST

4.66

16.8

1.20

mAb4

4.20

18.8

1.12

mAb5

6.60

21.7

1.15

mAb6

5.81

24.1

1.11

mAb1

NA

9.3

NA

mAb2

5.00

12.3

1.32

NIST

4.16

14.4

1.17

mAb4

3.45

15.8

1.10

mAb5

6.25

18.1

1.14

mAb6

4.82

19.8

1.09
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123

128

159

161

215

Figure 4.24. PolyPENTYL A column with 1500 Å and 2 µm particle size: Impact of MeCN
percentage on peak capacity (MP A: 1 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0.

Figure 4.25. PolyPENTYL A column with 1500 Å and 2 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0. 5 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0.
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Figure 4.26. PolyPENTYL A column with 1500 Å and 2 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0. 35 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc
with different percentages of MeCN with an aqueous pH 7.0).
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Table 4.11. Comparison of chromatograms with 0.35 M ammonium acetate as mobile phase A
and 50%, 65% and 75% of MeCN with 20 mM ammonium acetate as Mobile phase B using
PolyPENTYL A column with 2 µm, 1500 Å pore size.

Mobile phase
composition

0.35M and
20mM with
50%MeCN

0.35M and
20mM with
65%MeCN

0.35M and
20mM with
75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

3.32

NA

mAb2

12.73

21.2

6.08

NIST

2.97

23.7

1.12

mAb4

2.70

25.8

1.09

mAb5

5.68

30.3

1.17

mAb6

6.36

40.7

1.34

mAb1

NA

3.16

NA

mAb2

11.29

18.3

5.47

NIST

2.58

19.9

1.09

mAb4

3.41

22.1

1.11

mAb5

4.16

24.5

1.11

mAb6

8.48

30.6

1.25

mAb1

NA

3.00

NA

mAb2

10.46

15.5

4.92

NIST

2.21

16.7

1.07

mAb4

3.69

18.5

1.11

mAb5

2.85

19.8

1.07

mAb6

8.89

24.3

1.22
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Retention Factor

74

105

128

Figure 4.27. PolyPENTYL A column with 1500 Å and 2 µm particle size: Impact of MeCN
percentage on peak capacity (MP A: 0.35 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).

Figure 4.28. PolyPENTYL A column with 1500 Å and 2 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0. 25 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc
with different percentages of MeCN with an aqueous pH 7.0).
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4.3.5 PolyBUTYL A column with 1000 Å pore size with 3 µm particle size
PolyBUTYL A column with 1000 Å with 3 µm particle size showed very similar selectivity
to PolyPENTYL A column (control) with the same column parameters using 1M ammonium
acetate as mobile phase A and 20mM ammonium acetate with different concentrations of MeCN
as mobile phase B. Mobile phase B with 25% MeCN did not elute all the peaks but selectivity
improved significantly with 35% MeCN. With 1M salt concentration, adequate chromatographic
separation was achieved in a combination with a MeCN concentration of 50% and above (Figure
4.29) showing an increase in the peak capacity (Figure 4.30). Results of the chromatographic
parameters are listed in Table 4.12. Mobile phase A with 0.5 M and mobile phase B with
different percentages MeCN demonstrated no elution or co-elution of peaks (Figure 4.31).
However, and the unlike PolyPENTYL A column with same pore and particle size, butyl column
with 1000 Å and 3 µm showed good selectivity and acceptable resolution using 0.35 M with
65% and 75% MeCN (Figure 4.32). This behavior is a good example to explain the importance
of stationary phase alkyl chain length which plays a significant role it plays in obtaining good
selectivity in HHIC separation. Similar to 1500 Å with 2 µm column, this column also showed
the separation of variants for mAb4 in the presence of mobile phase A containing 0.25 M with
mobile phase B with 75% MeCN. This combination of stationary and mobile phase conditions
can be helpful to separate minor variants of a mAb (Figure 4.33). Peak capacity was calculated
only for the conditions where chromatographic separation was achieved.
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Figure 4.29. PolyBUTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 1 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Table 4.12. Comparison of chromatograms with 1 M ammonium acetate as mobile phase A and
35%, 50%, 65% and 75% of MeCN with 20 mM ammonium acetate as Mobile phase B using
PolyBUTYL A column with 3 µm, 1000 Å pore size.
Mobile phase
composition

1M and 20mM
with 35%MeCN

1M and 20mM
with50%MeCN

1M and 20mM
with 65%MeCN

1M and 20mM
with 75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

29.5

NA

mAb2

4.88

40.8

1.39

NIST

2.17

45.5

1.11

mAb4

3.65

52.2

1.15

mAb5

3.30

57.9

1.11

mAb6

5.69

69.2

1.19

mAb1

NA

24.5

NA

mAb2

4.34

31.7

1.30

NIST

2.06

34.7

1.10

mAb4

2.77

38.2

1.10

mAb5

3.94

42.8

1.12

mAb6

4.20

47.6

1.11

mAb1

NA

22.5

NA

mAb2

4.06

28.3

1.26

NIST

1.94

30.7

1.09

mAb4

2.40

33.3

1.08

mAb5

4.02

37.4

1.12

mAb6

3.48

40.8

1.09

mAb1

NA

20.2

NA

mAb2

3.79

24.7

1.23

NIST

1.77

26.5

1.07

mAb4

2.06

28.4

1.07

mAb5

3.94

31.7

1.12

mAb6

2.98

34.4

1.08
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Retention Factor

79

118

131

164

Figure 4.30. PolyBUTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on peak capacity (MP A: 1 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).

Figure 4.31. PolyBUTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.5 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Figure 4.32. PolyBUTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.35 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
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Table 4.13. Comparison of chromatograms with 0.35 M ammonium acetate as mobile phase A
and 65% and 75% of MeCN with 20 mM ammonium acetate as Mobile phase B using
PolyBUTYL A column with 3 µm, 1000 Å pore size.
Mobile phase
composition

0.25M and
20mM with
65%MeCN

0.25M and
20mM with
75%MeCN

Peak name

Resolution

Retention
Factor

Selectivity

mAb1

NA

17.5

NA

mAb2

9.68

39.0

2.23

NIST

2.08

42.7

1.11

mAb4

1.13

44.8

1.05

mAb5

2.33

48.5

1.08

mAb6

5.58

59.6

1.23

mAb1

NA

16.1

NA

mAb2

9.22

32.4

2.04

NIST

1.97

35.2

1.09

mAb4

1.58

37.4

1.06

mAb5

1.46

39.1

1.05

mAb6

5.86

47.2

1.21
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Retention Factor

37

52

Figure 4.33. PolyBUTYL A column with 1000 Å and 3 µm particle size: Impact of MeCN
percentage on the selectivity (MP A: 0.25 M NH4OAc at pH 7.0 and MP B: 20 mM NH4OAc with
different percentages of MeCN with an aqueous pH 7.0).
Upon reviewing the above five columns, considerable selectivity differences were observed
with respect to alkyl chain lengths, pore and particle sizes. In addition, there are some very
important observations in the chromatographic separations which can open the doors to explore
separate variants of biomolecules in HHIC, which has been a challenges thus far.
PolyPENTYL A column with 1000 Å with 2 and 3 µm particle sizes gave very similar
selectivity with 1 M mobile phase A, but 3 µm showed selectivity with 0.5M which was not
obtained using 2 µm column. When compared columns with same pore sizes but different
particle sizes, columns with smaller particle size retained molecules much stronger resulting in
poor recovery. Comparing both PolyPENTYL A column with 1500 Å pore size with 2 µm and 3
µm particle sizes, unlike 3 µm column, 2 µm particle size column was able to elute peaks with
both 1 M in combination with 25% MeCN and 0.35 M with 50% to 75% MeCN. However,
between 2 µm and 3 µm, 3 µm column provided adequate elution in 0.25 M in the presence of
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65% and 75% MeCN. The reason for stronger retention in 2 µm for both 1000 Å and 1500 Å is
the availability of a larger surface area for adsorption.
Experimental results demonstrated that PolyPENTYL A and PolyBUTYL A columns gave
adequate separation using 1 M in combination with 35% and higher MeCN concentration in
20mM ammonium acetate. However, column with 1000 Å, 3 µm separated molecules using 0.5
M in the presence of 50% and 65% MeCN in mobile phase B. PolyPENTYL A 1500 Å and
PolyBUTYL A 1000 Å columns with 3 um pore size were able to provide separation using 0.35
M with 50% and higher MeCN content. PolyPENTYL A column with 1500 Å with 2 µm pore
size can separate molecules with 0.25 M with 75% MeCN in mobile phase B. Unlike any other
conditions in this study, 0.25 M salt as the starting concentration, the 2 µm, 1500 Å
PolyPENTYL A column and 3 µm, 1000 Å PolyBUTYL A column demonstrated two minor
variant peaks. With these results it was clear that the variations in column parameters such as
alkyl chain with different particle and pore sizes have a significant impact on the
chromatographic separation. In addition, it was proven that salt concentration played a critical
role and impacted the hydrophobic interactions by altering the selectivity of mAbs. Hence, it is
highly beneficial to screen the stationary phase parameters to achieve chromatographic
performance based on the separation requirements. It has been well established that increase in
pore size will decrease the surface area, but in these columns, the difference in the surface area
due to the changes in pore and particle size may not be significant. However, the difference in
the pressure may contribute to subtle changes in the molecule conformation. If any there are any
minor structural alterations in molecule’s tertiary structure are prevented by intramolecular
crosslinks, then the access to the hydrophobic patches can be restricted and can result in faster
elution. As HIC is very sensitive to these minor changes it may affect the adsorption. However,
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the interplay of salt concentration and pore size between 1000 Å and 1500 Å is inconclusive and
need further investigation.
The columns and the conditions that showed adequate separation are listed in the below
table.
Table 4.14. Summary of different phase systems that gave adequate separation.
Column

Pore and particle size
1000 Å, 3 µm

PolyPENTYL

1000 Å, 2 µm
1500 Å, 3 µm
1500 Å, 2 µm

PolyBUTYL

1000 Å, 3 µm

Mobile phase A
1M
1M
0.5 M
1M
1M
0.35 M
0.25 M
1M
0.35 M
1M
0.35 M

% of MeCN in mobile phase B
50 (Control)
35, 65 and 75
50 and 65
35, 50, 65 and 75
35, 50, 65 and 75
50 and 65
75%
25, 35, 50, 65 and 75
50, 65 and 75
35, 50, 65 and 75
65 and 75

Note: Mobile phase A is ammonium acetate concentration, mobile phase B is 20 mM ammonium
acetate (overall) with different percentages of MeCN.
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4.3.6 Comparison of peak capacity in different phase systems
To provide a head to head comparison all five columns were compared using the selectivity
that was obtained at the control mobile phase conditions of 1M in combination with 50% MeCN
in 20 mM salt concentration. In these conditions all five columns gave adequate separation
(Figure 4.34). The above experimental data demonstrated that column pore size and particle size
contributed to the modification of molecule retention due to the differences in the available
surface area. Columns with low surface area gave better peak shape and resolution compared to
other columns, in addition, low surface area promoted early elution for some mAbs but not all.
These stationary phases are newly developed and not completely optimized. The
chromatographic performance changes might be due to the differences in the other parameters
not limited to only pore size and particle size. Drawing a conclusion to predict the differences in
selectivity using the low salt conditions with different column parameters needs further
evaluation.
The novelty of this research was to demonstrate the utility of HHIC for the first time by
studying a mixture of mAbs under these salt conditions using poly (alkyl aspartamide) silica
columns. The goal was to achieve adequate separation at lower salt concentrations with an
organic percentage which can still maintain the folded confirmation of the molecule and enhance
the MS signal. This data provided very useful insights indicating that these mobile phase and
stationary phase conditions can be further evaluated to achieve HHIC separation with online MS
capability.
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Figure 4.34. Comparison of PolyPENTYL A and PolyBUTYL A columns with different pore and
particle sizes: (MP A: 1 M NH4OAc and MP B: 20 mM NH4OAc with 50% MeCN with an
aqueous pH 7.0). Note: Sample mixture used in 2 µm was different from the sample mixture used with 3 um
columns.

4.3.7 Impact of high organic content in mobile phase B
Biomolecules retention on HIC columns is very sensitive to the percentage of organic
solvent, specifically MeCN, in this case. This study demonstrated that some columns gave
adequate separation and increased peak capacity with more than 50% MeCN in mobile phase B.
Under conditions with more than 50% MeCN in combination with low salt concentrations,
neither spilt peaks nor additional peaks were observed indicating conformational changes.
However, it is a well-known fact that an increase in organic content can induce conformational
changes, and it is important to make sure mobile phase with higher organic content will not
disturb the conformational stability of a molecule. To gain some preliminary knowledge about
the structural changes of a biomolecule in the presence of acetonitrile, experiments using
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orthogonal techniques such as intrinsic fluorescence were performed and results were presented
in Chapter 5.

4.3.8 Column to column variability: Comparison of PolyPENTYL A columns
In our research it was observed that chromatographic retention under HHIC stationary
phases is highly sensitive to mobile phase and stationary phase parameters. Chromatographic
variations from batch to batch were observed (Figure 4.35). This result can be due to minor
differences in the columns such as pore diameter, pore volume, surface area in the stationary
phase and packing of the material. In addition, the combination of stationary phase properties
with minor differences in mobile phase composition can impact the retention. As these stationary
phases are newly developed and additional optimization may enhance chromatographic
performance. For qualitative assessment, the shift in the peaks may not have an impact, however,
it is important to keep in mind during method development experiments and method transfer.
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Figure 4.35. Comparison of PolyPENTYL A columns using the same lot of bulk stationary phase
(MP A: 1 M NH4OAc and MP B: 20 mM NH4OAc with 50% MeCN with an aqueous pH 7.0).

4.3.9 Comparison of TSKGel Butyl-NPR and PolyPENTYL A columns
To compare the selectivity of the selected mAbs on commercially available columns, a
sample mixture and individual mAbs were analyzed using Tosoh TSKGel Butyl-NPR column
with phosphate and sulfate as mobile phases, which are commonly used for HIC separations.
Peaks co-eluted on the Butyl-NPR column showing lack of selectivity (Figure 4.36 and Figure
4.37). This experiment demonstrates that either Butyl-NPR column may not be suitable to
separate this mixture or the method needs to be optimized to evaluate suitable mobile phase
conditions. The same sample mixture gave an adequate separation with PolyPENTYL A column
using a combination of ammonium acetate and 50% MeCN showing the utility of the column to
separate molecules with very low surface hydrophobicity differences.
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Figure 4.36. Comparison of PolyPENTYL A and Tosoh TSKGel Butyl-NPR columns with (MP A:
1 M NH4OAc and MP B: 20 mM NH4OAc with 50% MeCN with an aqueous pH 7.0 and MP A:
20 mM sodium phosphate, 1.5 M ammonium sulfate, 500 mM Arg and MP B: 20 mM sodium
phosphate, 500 mM Arg, pH 7.5).

Figure 4.37. Selectivity of individual mAbs on Tosoh TSKGel Butyl-NPR columns with MP A: 20
mM sodium phosphate, 1.5 M ammonium sulfate, 500 mM Arg and MP B: 20 mM sodium
phosphate, 500 mM Arg, pH 7.5.
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4.4 Conclusion
The purpose of this study was to evaluate the impact of chromatographic parameters on
the chromatographic performance using poly (alkyl aspartamide) silica columns. It was evident
that pore size, particle size, alkyl length has a significant impact on the selectivity due to the
available surface area. Together, these parameters effected diffusion and retention of the
molecule. Along with column parameters, mobile phase parameters such as concentration of salt
at the starting condition and percentage of MeCN used to disrupt the hydrophobic interactions
contributed to adequate elution. In addition, concentration of salt at the starting condition altered
the order of mAbs elution by modifying the selectivity.
Assessment of chromatographic performance on multiple PolyPENTYL A columns
demonstrated that even though pore size and particles sizes appear to be similar, there may have
been some variations in column parameters that needs further investigation to achieve robustness
and overcome column to column variability.
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Chapter 5 : Evaluation of mAb Conformational Changes Using
Intrinsic Fluorescence: Influence of Chromatographic Parameters
5.1 Introduction
HHIC mobile phase conditions can contribute to significant changes in biomolecule
conformation. Salts can either promote solubility or induce self-association or aggregation. In
addition, structural differences such as secondary and tertiary structure can be highly impacted
by the organic content including the type, amount and contact time with the biomolecule1-6
The evaluation of poly (alkyl aspartamide) stationary phases with butyl and pentyl alkyl
chains with 1000 Å and 1500 Å pore sizes and 2 µm and 3 µm particle sizes showed adequate
separation with different mobile phase conditions described in Table 4.2.4. With respect to
chromatography (Refer to Chapter 4), the peaks in most of these experiments appeared
homogeneous with very low or no observation of variants. To study conformational changes and
structure evaluation of a biomolecule, there are various techniques available, such as Circular
Dichroism (CD)
transfer (iFRET)

7-9

, protein NMR

14-15

10-13

and intrinsic Fluorescence resonance energy

. To conduct a preliminary screening of conformational changes,

experiments were performed using intrinsic fluorescence, which is an indicator for
conformational changes in biomolecules with respect to changing tryptophans environment.
Even though this technique does not provide conformation details of a biomolecule as NMR 16-17
does, it can be very useful tool for screening because of its sensitivity to changes in the
conformational and dynamic properties due to solvent changes
analysis time.
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18

, high throughput and faster

Intrinsic fluorescence, also known as Tryptophan fluorescence, is widely used as a tool to
monitor changes in proteins and to make inferences regarding local structure and dynamics

19

.

Out of the three fluorescent amino acids that are present in biomolecules, tryptophan is the most
abundant

20

. The indole group of tryptophan is the source of UV absorbance at ∼280 nm and

emission is at a of range 330 - 350 nm 21 depending on the polarity of its local environment 20, 2227

. In addition, tryptophan fluorescence efficiency is strongly impacted by external and internal

quenchers 14. Tryptophan is a relatively rare amino acid; many biomolecules contain only one or
a few tryptophan residues. However, intrinsic protein fluorescence is very weak and will not
occur in biomolecules if tryptophans are absent 18. Compared to extrinsic probes, this technique
has an advantage of keeping the molecule unchanged. This technique is very sensitive, fast and
can be automated. Specifically, observing conformational changes in conjunction with thermal
changes, due to solvent differences can be very helpful. Identifying conformational changes
under temperature variations will help to characterize the thermal conformational stability of
molecules in solution as a function of the solution properties 18.
The basic principle of this technique is, when a biomolecule is in a folded state, the
spectral shift is towards lower wavelengths (i.e. higher energy and higher frequency), which is a
blue shift

28

, indicating tryptophans are in a hydrophobic environment

29

. Unfolded molecule

shifts towards higher wavelengths (i.e. lower energy and lower frequency) indicating a red shift
18

and the exposed tryptophans are in a hydrophilic environment. The spectral shift from blue to

red represents an unfolding of a biomolecule 30. Similarly a folded molecule 330/350 ratio is high
and as the molecule unfolds the ratio decreases

31

. The magnitude of the wavelength shift

depends on the extent to which the protein is buried in the native conformation and is exposed to
polar environment in the unfolded state 18.
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The aim of the study was to get an initial screening of the conformational changes under the
chromatographic conditions which provided satisfactory chromatographic separation. The
experiments were designed to evaluate the conformational changes separately in the presence of
different concentrations of salt (mobile phase A), different percentages of MeCN in 20 mM salt
(mobile phase B), and also in combination of both mobile phase A and mobile phase B. All six
mAbs were screened to select a most sensitive probe to observe conformation changes. This
screening experiment was carried out using an offline batch mode intrinsic fluorescence.
The results from this preliminary research provided useful information about mAb5
conformation in the presence of each mobile phase condition using offline batch mode intrinsic
fluorescence in addition to sample analysis using HPLC with a fluorescence detector. All of
these results will help to hypothesize the insights on structural modifications during the
chromatographic separation. However, this information may not be sufficient enough to draw
conclusions about conformational changes and additional techniques are required to evaluate the
changes in the conformation.

5.2 Experimental Details
HPLC grade water and MeCN were used in all analysis. NH4OAc solution was purchased
from Teknova, Hollister, CA. MeCN, was purchased from Sigma-Aldrich, 0.1N ammonium
hydroxide was purchased from Ricca Chemicals.

HIC column PolyPENTYL A, with

dimensions of 50 x 2.1 mm, 3 µm particles with a pore size of 1000 Å was obtained from
PolyLC INC, Columbia, MD. Chromatographic separations were performed using Waters
Acquity H-class HPLC system with FLR detector with a flow rate of 1.0 mL/min and spectra
was collected from 210-400 nm. Details about the molecules and chromatographic conditions
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were listed in Section 2.2. pH of aqueous solutions is 7. Offline batch mode intrinsic experiments
were performed using Prometheus NT.Plex nanoDSF. Intrinsic fluorescence spectra was
collected and the ratio was measured using 330 nm and 350 nm. Control (ctrl) sample was
prepared using HPLC grade water at 1 mg/mL to get a baseline of the native conformation in
addition to the samples that were prepared in mobile phase A and B according to Tables 5.1 and
5.2.

5.3 Structural Evaluation Using Intrinsic Fluorescence
To perform an initial assessment using intrinsic fluorescence, samples were prepared at 1
mg/mL concentration using HPLC grade water as the diluent to get a base line of the
conformation and also to select a best suitable mAb to perform experiments for further
conformational evaluation. The experiment was conducted by using thermal stress to unfold the
mAbs. MAb which showed the highest difference in F330/350 ratio was an indication of highest
unfolding. With a preliminary scan, mAb2 showed very low signal at 30% intensity compared to
other mAbs. Therefore, mAb2 was prepared at 5 mg/mL and rest of the mAb5 were kept at 1
mg/mL concentration. Experiments were carried out at a temperature range of 25°C to 90°C
using 30% excitation power to study deep conformational changes as compared to subtle
changes. The study was designed to observe conformational changes at 25°C, and also monitor
maximum shift in F330/350 ratio with respect to temperature variations to assess conformational
changes which can help to identify the better probe out of all six mAbs that were used. In
addition, thermal range was considered as a variable to observe conformational changes and to
have as an option to use higher temperatures as needed if the column is stable under high
temperatures. The results of F330/F350 ratio (Figure 5.1) showed that at 25°C, mAb1, mAb3 and
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mAb6 exhibited mostly exposed tryptophans which were exposed to outside hydrophilic
environment and mAb2 and mAb4 had some exposed. Conversely, the data showed that mAb5
existed with least number of exposed tryptophans, which were in hydrophobic environment.
Based on these observations, mAb5 was considered as the best choice to study the
conformational changes using different mobile phase conditions as described in Tables 5.1 and
5.2.

Figure 5.1. The measure of unfolding in water at 25°C to 90°C using F330/F350 ratio.
To study the conformational changes, mAb5 samples were prepared separately using
different concentrations of mobile phase A, 20 mM salt with different percentages of MeCN as
mobile phase B and also mixing both mobile phases to perform experiments as described in the
following tables 5.1 and 5.2.
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Table 5.1. Samples in different concentrations of mobile phase A and mobile phase B.
Sample

Mobile Phase A: Concentration of ammonium acetate (M) @ pH 7.0
1

mAb5

0.5

0.35

0.25

Mobile Phase B: % of MeCN in 20 mM ammonium acetate @ pH 7.0
25

35

50

65

75

Table 5.2. Samples prepared using mobile phase A with different percentages of mobile phase B
at 70:30 ratio.
70% of Mobile Phase A
mAb 5

1M

30% of Mobile Phase B
25

35

50

65

75

5.3.1 Impact of salt concentration (mobile phase A)
To study the impact of salt concentration, mAb5 samples were prepared using water as
control (Ctrl), 1 M, 0.5 M, 0.35 M and 0.25 M concentrations of ammonium acetate. The
biomolecule demonstrated no significant difference in F330/F350 ratio in these salt conditions at
25°C. In addition, at 25°C, the conformation of mAb5 was very similar to the conformation that
was observed in water. High F330/350 ratio indicated that the tryptophans were folded and
reside in protein’s interior hydrophobic environment. As the temperature increased from 25°C to
90°C, the molecule produced a red shift representing that the molecule had undergone unfolding
due to the thermal stress (Figure 5.2) which was also confirmed by the decrease in F330/350
ratio. This observation confirmed that tryptophans were exposed from a protein interior
hydrophobic environment to an external hydrophilic polar environment. At 25°C, the same
behavior was observed in all four salt concentrations, indicating that the changes in the molecule
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conformation among this concentration range were insignificant. Based on the results, it was
confirmed that at 25°C mAb5 existed in a folded state and also proved that salt with a
concentration range of 1 M - 0.25 M did not show any impact on mAb 5 conformation. Again the
salt impact may be different on different biomolecules.

Figure 5.2. MAb5 molecule conformation measured using F330/350 ratio in water and different
salt concentrations as mobile phase A in a temperature range of 25°C to 90°C.

5.3.2 Impact of different percentages of MeCN (mobile phase B)
The unfolding nature of the molecule was illustrated using mobile phase B, 20 mM
ammonium acetate (overall) with different percentages of MeCN. Experimental results
demonstrated that at 25°C, there was a significant difference in the molecule conformation with
an increase of MeCN content from 25% to 75% in mobile phase B with 20 mM ammonium
acetate. MAb5 showed a blue shift in the presence of 25% MeCN which confirmed the
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molecule’s folded conformation. This observation was very similar to the conformation in water
and also in different salt concentrations (Figure 5.2 and 5.3). As MeCN concentration in mobile
phase B increased from 25% to 50%, the molecule showed unfolding which was represented by
the decrease in F330/350 ratio and a red shift by moving to a higher wavelength. The
concentration further increased to 65% and to 75% MeCN, the F330/350 ratio slowly increased
showing indications of aggregation resulting in a blue shift (Figure 5.4). Using this technique,
the presence of 20 mM with 25% MeCN demonstrated no major changes in the conformation.
The assumption was, 25% MeCN in mobile phase may be not strong enough to disrupt noncovalent interactions to unfold the molecule, and however, as the percentage increased to 35%
and above, the conformation was impacted due to disrupted interactions and lead to an unfolding
which eventually resulted in aggregation. A non-monotonic change of shifting to red and then
back to blue generally indicates that the tryptophans were turning into a more hydrophobic
environment which is associated with an aggregation. The hypothesis for the aggregation at
higher concentrations of salt solutions can be supported by the physical observation of
cloudiness during the sample preparations.
The impact of organic content varies the way a biomolecule is exposed to the organic
content. Samples were prepared using premixed mobile phase B, 20 mM with 25% to 75% of
MeCN. The effect may vary if water added first and MeCN follows or vice versa. Earlier
research
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proved that proteins denature in aqueous-organic mixture but not pure organic

content. Organic solvents expected to disrupt hydrophobic and other non-covalent interactions of
a protein (Refer to Section 3.2). As demonstrated by Meng, water and MeCN mixture tend to
weakens electrostatic interactions 33.
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The observations from this experiment supported the hypothesis of possible
conformational changes in the presence of 20 mM with different concentrations of MeCN due to
low salt environment. However, to gain more knowledge on structural changes under the above
solvent conditions other conformational evaluation experiments are required.

Figure 5.3. MAb5 confirmation measured in different concentrations of MeCN in mobile phase
B using F330/F350 ratio from 25°C to 90°C.
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Figure 5.4. MAb5 confirmation measured in 20 mM with different concentrations of MeCN as
mobile phase B using F330/F350 ratio at 25°C.

5.3.3 Impact of mobile phase composition
HHIC experiments with various concentrations of mobile phase A and mobile phase B
showed that mAb5 eluted within a range of 50% - 62% mobile phase A in combination with 54%
- 27% of mobile phase B containing 20 mM ammonium acetate. Samples were prepared only in
those conditions where the separation was adequate. In an effort to mimic the chromatographic
elution conditions, the sample was first mixed with mobile phase A then mobile phase B was
added to bring the sample concentration to 1 mg/mL. Experimental design was as indicated in
the Table 5.3.
The purpose of this experiment was to assess the tolerability of the molecule
conformation in the mobile phase composition. Based on the observation, there was a significant
variation in the molecule conformation with an increase from 25% to 75% of mobile phase B
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with 20 mM ammonium acetate in combination with mobile phase A salt concentration that was
used in this study.

Table 5.3. Samples prepared using mobile phase A and mobile phase B.
Mobile Phase A

MAb5

20 mM ammonium acetate containing different
% of MeCN as mobile phase B

Ammonium acetate
concentration

35

50

65

75

1M

x

x

x

x

0.5 M

-

x

x

x

0.35 M

-

x

x

x

0.25 M

-

-

x

x

Note: “x” - Conditions used to prepare samples
Intrinsic fluorescence results from 1 M and 0.35 M as mobile phase A with different
percentages of organic in mobile phase B (Figure5.5, 5.6 and 5.7) at 25°C supported the
assumption of biomolecule conformational stability under high salt concentrations.

No

difference in fluorescence ratio demonstrated that there was no change in tryptophan
environment under these conditions and molecule existed in folded state. As the temperature
increased from 25°C to 90°C, a red shift indicated that tryptophans were exposed to hydrophilic
environment due to an unfolding of the molecule. Unlike other higher salt conditions, 0.25M as
mobile phase A and 20 mM with 65% and 75% MeCN as mobile phase B showed considerable
change in fluorescence ratio, which was an indication of change in molecule confirmation due to
low salt condition (Figure 5.9). However, a non-monotonic increase in F330/350 ratio under
0.25M and 20 mM with 75% MeCN can be a sign of possible aggregation. By evaluating the
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effect of mixture of mobile phase (A and B) with mobile phase A (section 5.5) and mobile phase
B (section 5.6) separately, it was clear and supported the hypothesis of the role of MeCN is
highly dependent upon the salt concentration. 0.25 M as mobile phase A, the salt concentration
was helping to reduce the unfolding by holding the tryptophan hydrophobic environment. Where
as in mobile phase B containing 20 mM with 65% and 75% MeCN, the absence of salt was
promoting unfolding by weakening the non-specific interactions.

Figure 5.5. MAb5 confirmation measured in 1M with different concentrations of MeCN in
mobile phase B using F330/F350 ratio from 25°C to 90°C
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Figure 5.6. MAb5 confirmation measured in 0.5M as mobile phase A with different
concentrations of MeCN in mobile phase B using F330/F350 ratio from 25°C to 90°C

Figure 5.7. MAb5 confirmation measured in 0.35M as mobile phase A with different
concentrations of MeCN in mobile phase B using F330/F350 ratio from 25°C to 90°C
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Figure 5.8. MAb5 confirmation measured in 0.25M as mobile phase A with different
concentrations of MeCN in mobile phase B using F330/F350 ratio from 25°C to 90°C
Intrinsic fluorescence data demonstrated that mAb5 showed conformation changes in the
presence of mobile phase A, mobile phase B and in the mixture of both mobile phases. Out of all
these conditions, mAb5 retained its folded conformation in a mixture of mobile phase A with a
range of 1 M to 0.35 M and mobile phase B as 20 mM with 75% MeCN. However, mAb5
aggregated in the presence of mobile phase B containing 20 mM with 75% MeCN alone. Upon
reviewing the above two experiments, it was clear that when mobile phase A (1 M to 0.35 M)
was added to mobile phase B with 75% MeCN, the tryptophan environment was protected by
keeping the molecule in its folded state. This result demonstrated that the impact of 75% MeCN
was insignificant on intrinsic florescence changes in the presence of higher salt concentration
which is above 0.35 M ammonium acetate. The assumption was, that higher salt may have
protected mAb5 conformation. Under high salt conditions, the biomolecule existed in the folded
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state resulting in a blue shift with high F330/350 ratio. However, the data indicated that mAb5
may have unfolded in the presence of mobile phase A with 0.25 M and mobile phase B
containing 20 mM with 75% MeCN showing a decrease in F330/350 ratio (Figure 5.8 and Figure
5.9). This intrinsic experimental data indicating possible unfolding in low salt with high organic
content environment supports the hypothesis of high organic content can have a huge impact on
molecule conformation, however, in the presence of high salt environment the impact is low due
to the conformational stability. In contrary, in low salt environment high organic content can
influence the molecule confirmation by causing partial unfolding or unfolding. The observation
of red shift in 0.25 M and 20 mM with 75% MeCN was an indication of change in tryptophan
environment which was caused as a result of the molecule partial unfolding or unfolding.

Figure 5.9. MAb5 confirmation measured in different concentrations of salt as mobile phase A
and 75% of MeCN in mobile phase B using F330/F350 ratio from 25°C to 90°C
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5.3.4 Impact of mobile phase and stationary phase interplay
Stationary phase evaluation (Chapter 4) demonstrated PolyPENTYL A 1500 Å with 2 um
and 3 um particle size and PolyBUTYL A 1000 Å with 2 um and 3 um particle size columns
exhibited adequate separation using 0.25 M and 0.35 M as mobile phase A in combination with
20 mM with 65% and 75% MeCN as mobile phase B. To investigate the biomolecule
conformation in these relatively low salt concentrations with high MeCN, the same HHIC
experiments were repeated using a HPLC system with intrinsic fluorescence detector. The data
was calculated using F330/350 ratio. The primary aim of this experiment was to study the role of
hydrophobic stationary phase on the biomolecule conformation in the presence of mobile phase
gradient. The F330/350 ratio from chromatographic data and the standalone intrinsic
experimental results were evaluated to build a hypothesis to explain the conformational changes
in mAb5 when exposed to chromatographic conditions.
Results from the experiments indicated that along with mobile phase A with 1 M and
mobile phase B containing 20 mM with 50% MeCN, mobile phase A with 0.25 M and 0.35 M in
a combination with 20 mM with 65% and 75% MeCN in mobile phase B, showed very similar
F330/350 ratios. Correlating chromatographic data with batch mode intrinsic data, mAb5
behavior in different salt concentrations in combination with different percentages of organic
solvent at 25°C (Figure 5.10) showed that the molecule existed mostly in aggregated state.
However, as there were not enough data points to observe the trend of conformational changes,
the outcome is inconclusive. To perform a complete assessment on unfolding and aggregation of
mAb5 molecule, a future experimental study should be planned to gather information with
multiple data points using different percentages of MeCN in combination with different salt
concentrations.
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Figure 5.10: MAb5 confirmation measured in mobile phase A and different concentrations of
MeCN in the presence of mobile phase B using F330/F350 ratio at 25°C.
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5.4 Conclusion
The results from batch mode intrinsic fluorescence and HHIC fluorescence detector
experiments indicated that the salt in mobile phase A (1 M - 0.35 M) helped to retain mAb5
conformation from unfolding in the presence of 20 mM containing 75% MeCN by supporting the
hypothesis. According to these preliminary experiments using mAb5 and intrinsic fluorescence
technique, the results from both mobile phases A and B and the mixture of mobile phases (A and
B) suggested that the low salt conditions mentioned in Table 4.14 (such as 0.35M and 0.25M
with 20 mM containing 65% and 75% MeCN in mobile phase B) can be used to achieve
adequate separation by keeping the molecule in non-denatured form. To obtain more details on
the trend of unfolding/aggregation, additional experiments need to be performed by changing the
MeCN concentration from 25% to 75% MeCN in mobile phase B.
The conformational evaluation using intrinsic fluorescence was done for the first time to
gain knowledge on a mAb’s existence under the influence of HHIC chromatographic parameters.
Results obtained from this small set of experiments using mAb5 provided fundamental
knowledge about possible conformational changes based on intrinsic fluorescence data and also
brought out some important questions to extend the research and further evaluate to obtain
deeper understanding on the conformation of biomolecules under HHIC chromatographic solvent
conditions. All of these experiments were performed with one mAb using one technique to
assess the conformational changes. To expand this knowledge, the research can be continued to
evaluate the changes in multiple mAbs and related biomolecules using techniques such as
intrinsic fluorescence Förster resonance energy transfer (FRET), Circular Dichroism (CD), Static
Light Scattering (SLS) and Dynamic Light Scattering (DLS) and also protein NMR can provide
details about the structure, weight and size along with aggregation and unfolding of a molecule.
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Collectively, these techniques can help to provide more insights to confirm the existence of
biomolecule conformation (unfolded state, native-like or aggregated state).
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Chapter 6 : Research Conclusions

Co-formulated monoclonal antibodies (mAbs) and other related biomolecules are very
important and fastest growing therapeutic modalities for various diseases.

To develop,

characterize and accurately quantitate multiple biomolecules simultaneously is extremely
important and highly challenging. There is a need to develop innovative technologies to address
limitations and resolve the challenges. This research is to study chromatographic retention and
enhance knowledge about HHIC and also provide possibilities to resolve some of the limitations
to assess critical parameters of chromatographic separation.
This dissertation provides new insights about HHIC capabilities to evaluate mixture of
mAbs using poly (alkyl aspartimide) columns, which can also facilitate MS compatibility. This
research provides useful information on working range of mobile phase parameters such as salt
concentration, pH, organic modifier and temperature to achieve adequate separation. The study
design also expands the knowledge of stationary phase properties such as hydrophobicity,
particle size and pore sizes that contribute towards achieving adequate separation under low salt
conditions to enhance ESI/MS signal, while keeping the molecule in folded or native-like
confirmation. The highlights are:
•

This novel research demonstrated the utility of HHIC for the first time using a mixture of
mAbs and separate them simultaneously.

•

In this research the utility of salt concentration was illustrated by demonstrating that
adequate separation is achievable using low salt concentration despite earlier reports to
the contrary. In addition, low salt (0.5M) provided superior chromatographic separation
and significant improvement in ESI/MS response. The improvement in separation is a
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result of reduced retention of early eluting components combined with an unexpected
greater retention of later eluting components which results in a widening the
chromatographic window (increased peak capacity). The new finding is use of low salt as
a starting condition to obtain greater retention which is atypical HIC behavior. The
improvement in ESI/MS response, which is a direct result of the use of lower salt
concentration, also represents a significant enhancement since the main motivating factor
of hybrid HIC is to enable online MS compatibility to HIC separation.
•

With 0.25 M salt as the starting concentration, the 2-µm, 1500-Å PolyPENTYL A
column exhibited two minor variant peaks that were not observed in any other
chromatogram in this research. This research demonstrated that low salt not only
improves ESI/MS signal but can be further evaluated to separate minor variants of a
mAb.

•

Conformational analysis confirmed mAb5 existed in folded or native-like conformation
under low salt conditions (0.25 M and 0.35M) in combination with high MeCN (65% and
75%).

•

The results of gradient steepness and linearity velocity indicate that the impact of these
parameters followed expected tendencies with a relatively modest loss of efficiency at the
highest linear velocity.

•

A pH range of 5.7 - 7.3 was evaluated as most of the biomolecules exhibit high chemical
and physical stability. The results indicated that when pH was close to the pI of the
molecule a decrease in retention was observed for some molecules and no impact on
others. This behavior was a result of a decrease in the charge of a molecule which was a
result of pH of the mobile phase. The study also demonstrated the impact of pH is
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complex because it is mainly driven by the properties of the molecule with respect to the
charged moieties. Even though pH may not a critical parameter, it can be used to widen
the chromatographic window and optimize the separation.
•

It has been well established that in HIC methodology organic modifier decreases the
retention. These experimental results confirmed that to perform HIC on poly(alkyl
aspartimide) columns, organic solvent is required to disrupt hydrophobic interactions and
elute peaks when low concentrations of ammonium acetate was used for the separation.
Evaluation of different organic solvents illustrated that adequate separation was achieved
using a non-polar solvent, such as MeCN but a polar solvent such as IPA produced more
complex chromatogram with multiple peaks for each component. It appears IPA enables
the separation of variants which was not observed with MeCN. Use of IPA can be further
evaluated to gain knowledge on separating variants. This is a valuable finding opens up
an opportunity to use IPA for separating variants and use MeCN to quantitate as an
ensemble of biomolecule depending upon the type of analysis.

•

In conventional HIC columns, increase in the temperature increase the retention. For the
first time the effect of temperature (20°C - 30°C) on these columns was evaluated and the
results indicated that with an increase in temperature, retention decreased. This is atypical
behavior of HIC columns. This result may be due to the changes in the diffusion of the
molecule through the stationary phase or in lower temperatures hydrophobic effect
becomes weaker.

•

The study to evaluate the effect of stationary phase hydrophobicity indicated that column
parameters significantly impact selectivity. PolyPROPYL column was unable to retain
molecules, however, as the alkyl chain length increased to HEPTYL early eluters
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demonstrated failed to elute and later eluters coeluted showing the impact of stationary
phase hydrophobicity.
•

Column pore size and particle size contributed to the modification of molecule retention
due to the differences in available surface area. Columns with low surface area gave
better peak shape and resolution compare other columns. The low surface area promoted
early elution for some mAbs but not all. These stationary phases are newly developed and
yet to be optimized, therefore, some of the chromatographic performance changes may be
due to the differences in other column parameters than just pore size and particle size.
Drawing a conclusion to predict the difference in selectivity using the low salt conditions
with different column parameters needs further evaluation.
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